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CHAPTER 1: INTRODUCTION
I. Herpesviruses
The name herpes comes from the Greek verb “έϱπειν” meaning “to creep” and
was originally used to describe various recurring skin infections (4). Since the time of
Hippocrates, the use of the term “herpes” has been continually refined based on observed
characteristics of infection. Eventually, herpes came to describe infections resulting in
formation of small transient pustules that were resistant to other treatments. In the initial
17th through 19th century classifications of the genus Herpes, H. zoster and H. simplex
were first identified.
Through advances in technology and the characterization of viruses in modern
times, the genus Herpesvirus was officially recognized by the International Committee of
Taxonomy of Viruses (ICTV) starting in 1971 (5). Since then, the genus has been
elevated to the order Herpesvirales and now contains over 130 species divided into three
families based on host speciation: Herpesviridae (mammal, bird, and reptile),
Alloherpesviridae (fish and frog), and Malacoherpesviridae (mollusks).

The human

herpesviruses (HHVs) are contained within Herpesviridae and help comprise three
subfamilies: Alphaherpesvirinae includes herpes simplex virus 1 (HSV-1, HHV-1), herpes
simplex virus 2 (HSV-2, HHV-2), and varicella zoster virus (VZV, HHV-3);
Betaherpesvirinae includes human cytomegalovirus (HCMV, HHV-5), HHV-6A, HHV-6B,
and HHV-7; finally, Gammaherpesvirinae includes Epstein-Barr virus (EBV, HHV-4) and
Kaposi’s sarcoma-associated herpesvirus (KSHV, HHV-8).

Based on evolutionary

phylogeny, divergence of the Herpesviridae subfamilies happened ~180-220 million years
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ago whereas Homo sapiens are estimated to have evolved only ~1.3-1.8 million years
ago (6).
HHVs vary broadly in their tissue tropism and, as a result, are associated with a
wide range of etiologies with contrasting degrees of severity in healthy individuals. HSV1 and HSV-2 cause oral and genital lesions, respectively, and are classified as cofactors
for sexually transmitted infections.
shingles.

VZV is the causative agent of chicken pox and

HHV-6A, HHV-6B, and HHV-7 are all associated with roseola in infants.

Infectious mononucleosis is caused by EBV and to a lesser degree, HCMV. Lastly, HSV1, EBV, and KSHV infections have also been correlated with the development of cancer.
Despite differences in virion tropism and disease progression, HHV virions
maintain a conserved structure similar to all herpesviruses (7). Mature virions range from
100-200 nm in size and contain a large linear double-stranded DNA genome packaged
within an icosahedral nucleocapsid (Fig. 1.1). Within HHVs, genomes range from 145240 kbp in size and vary in terms of coding potential and sequence organization (Fig. 1.2)
(8). The capsid is then wrapped in a proteinaceous tegument which serves as a bridge
between the capsid and the envelope in addition to several key effector functions upon
infection. Ultimately, mature virions are wrapped in a host-derived lipid bilayer containing
membrane bound glycoproteins and accessory factors required for receptor binding and
membrane fusion during initiation of infection.
Similar to structure, the general replication cycle for HHVs is also conserved
between subfamilies (Fig. 1.3) (8). During lytic infection, virions attach the receptors on
host cell membranes. Following adherence, the virion envelope fuses with the plasma
membrane or endocytic vesicle thus releasing the tegument and nucleocapsid into the
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cytoplasmic space. The tegument downmodulates host immune responses while also
aiding in transport of the capsid to the nuclear membrane. Upon arrival at the nucleus,
the capsid portal is opened and the high internal pressure of the capsid ejects the viral
genome. Through a combination of tegument trans-activating proteins and host factors,
transcription of viral genes is initiated. This leads to the sequentially regulated expression
of viral proteins. Generally, immediate early (IE, α) genes promote replication by altering
the host environment, early (E, β) genes lead to DNA replication, and late (L, γ) genes
produce structural components used in assembly of nascent virions. When the infection
has sufficiently progressed, genome concatemers are packaged into the capsid which is
then exported out of the nucleus and into the cytoplasm. An amorphous tegument layer
is added and virions are enveloped. Finally, HHV progeny are exported out of host cells
into the extracellular space.
A hallmark of HHV infection is the ability to establish latency within host tissues.
In these instances, a low level of IE gene expression is maintained while the majority of
downstream genes are repressed through various mechanisms. Following cellular stress
or another appropriate stimulus, viral gene expression is induced and lytic replication
proceeds normally.
A. Global health burden of HCMV infection
Of all the HHVs, HCMV is one of the most pervasive and opportunistic pathogens
worldwide.

Seroprevalence has been shown to increase as a function of age with

approximately 60% of individuals being positive at 50 years of age (9).

Rates of

seroprevalence also tend to be disproportionately higher in both non-white and low
socioeconomic groups suggesting lifestyle-associated risk factors. In healthy individuals,
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primary symptoms are typically mild and may go unnoticed. Conversely, in individuals
with naïve or compromised immune systems, infection can have severe and lasting
effects.
HCMV is the leading infectious cause of congenital birth defects in the United
States (10). If a seronegative woman becomes infected prior to becoming pregnant, the
likelihood of fetal infection is low (11). If the same woman were to instead become
infected while pregnant, there is a 50% probability that the fetus will also be infected.
Even in healthy individuals, the normal immune response to HCMV is weakly protective.
Thus, if a mother contracts a previously unencountered strain of HCMV during pregnancy,
the risk for fetal infection increases. Of infected children, only 10% will show symptoms
although the other 90% may develop symptoms later.

The primary outcomes of

congenital infection are microcephaly, hearing loss, and growth retardation, among others
(12). During infection, the virus is able to access the fetus through infection of placental
cytotrophoblasts unless sufficiently controlled by the maternal immune response.
Infection of cytotrophoblasts also alters cellular gene expression and may impact the
support structures required for fetal development, particularly if infection occurs within the
first trimester.
In addition to congenital cases, HCMV is particularly problematic for
immunocompromised individuals, including HIV/AIDS patients and organ transplantation
patients. Because HCMV is so prevalent and establishes latency in hosts, individuals
with diminished immune systems are at high-risk for experiencing frequent viral
reactivations.
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Individuals infected with HIV were 2.5-times more likely to develop AIDS if they
were also HCMV-seropositive (13). For those who already developed AIDS, infection
with HCMV most often results in virally induced retinitis (14). The inability to mount a
sufficient neutralizing response to HCMV infection is correlated with decreased CD4+
leukocyte populations. The development of highly active antiretroviral therapy (HAART)
has led to dramatic improvements in the prognosis of AIDS patients but treatment can
also lead to temporary uveitis from reconstituted immune populations attacking remaining
viral antigens in the eye (15).
For solid organ transplant patients, CMV can be particularly problematic because
the virus exhibits an extraordinarily broad tissue tropism and is able to infect most major
organ systems. If a transplanted organ is directly infected or carries latently infected
monocytes, the new host may mount a strong CD8+ response against the new tissue
resulting in graft versus host disease and ultimate rejection of the organ.
For all at risk populations, the combination of improved screening techniques and
development of HCMV antiviral treatments has greatly reduced the incidence of
complications (16). Currently, there are four treatments available for HCMV: ganciclovir,
valganciclovir, cidofovir, and foscarnet. Thus far, vaccination strategies against HCMV
have been unsuccessful due to its unique immune evasion tactics meaning the antivirals
are the only option for treating patients. Unfortunately, all available drugs target either
viral DNA polymerase (UL54) or the phosphokinase, pUL97, so antiviral resistance has
increased. Hindering the development on novel therapies is a lack in understanding of
HCMV replicative processes.

In relation to several other clinically relevant viruses,
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comparatively little is known regarding HCMV virion assembly and egress. If these
processes were better understood, drug targets could be pursued.
B. HCMV replication and formation of the assembly compartment
During infection, HCMV follows a replication cycle similar to other herpesviruses
(Fig. 1.3). Where HCMV replication deviates most notably from the other herpesviruses,
is the formation of the assembly compartment. Approximately three days post-infection,
the host organelle structure is significantly altered through a process dependent on viral
gene expression (17-19). The internal reorganization of host membranes leads to the
generation of the cytoplasmic virion assembly compartment (cVAC; Fig. 1.4). The cVAC
is a structure unique to HCMV infection and consists of one or more enlarged nuclei bent
around a perinuclear ring-like Golgi structure with various endosome populations at the
center (18-20). In tissue sections of clinical specimens, these structures are referred to
as “owl’s eye inclusions.” The prevailing idea is that the cVAC functions as a viral
assembly line where the maturing capsids pass through the subsequent layers, gathering
the requisite structural proteins, until envelopment and egress.
Several studies have looked for proteins integral to cVAC biogenesis leading to
identification of both viral and cellular factors. An siRNA screen of viral genes identified
UL48, UL94, and UL103 as being important for induction of cVAC structures (21). After
establishing a direct role for UL103, a follow-up proteomics study characterized several
cellular proteins that interact with UL103 (22). By this study and others, the Golgi-resident
motor protein, MYO18A, was found to facilitate cVAC structure formation (22, 23).
The induction of cVAC formation is not required for virion growth but does augment
it. Several studies seeking to understand envelopment and egress of HCMV virions have
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found arrest of virion maturation is typically accompanied by improper localization of virion
structural proteins typically found in the cVAC. These observations lead to the question:
does cVAC development drive envelopment and egress or do envelopment and egress
drive cVAC development as a byproduct of virion production? To look at this interplay
further, we need to take a closer look at events required for envelopment and egress.
II. Envelopment and Egress
Several components are required for virion biogenesis including: i) the viral
genome, ii) capsid proteins, iii) viral microRNAs (miRNAs), iv) tegument proteins, v) lipid
membranes, and iv) membrane-bound glycoproteins. During infection with HCMV and
other herpesviruses, the host environment is heavily modified to generate the various
components and organize them along a novel biosynthetic pathway. If any one of the
components is absent or mislocalized, the stability of maturing particles is compromised
because the scaffold-like assembly of virions requires accurate construction at the
preceding stages. As an example, the ability for nascent virions to acquire the lipid
envelope is dependent on proper tegumentation.
Secondary envelopment of maturing virions takes place in the cytoplasmic space
and only proceeds following successful tegumentation. Similar to replication of HSV-1
and other herpesviruses, the lipid envelope is essential because it carries the necessary
glycoproteins and other signaling molecules to initiate infection upon release from the
host cell (24, 25). Envelopment is mediated by layers of tegument proteins interacting
with cellular lipid membranes in the assembly compartment, either directly through lipid
modifications or indirectly via membrane bound proteins (26). Through these interactions,
HCMV particles are engulfed by the target membranes and virion maturation is completed
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upon membrane scission (27). For the replication cycle to complete, the last remaining
stage is virion egress.
In addition to factors required for initiation of infection, membranes used during
envelopment define the route of virion egress (28, 29). The lipid composition of co-opted
membranes determines which cellular mediators of vesicle trafficking are able to interact
and by extension, the direction of transport (23). HCMV influences the route of exocytosis
through manipulation of fatty acid (FA) synthesis and resultant shifts in the balance of
various lipid moieties in the assembly compartment during infection (30, 31). Likewise,
several viral gene products also influence the stability and localization of proteins required
for vesicle transport, further driving the process (21, 32, 33). Through this multi-faceted
approach, HCMV virions are carried along a pathway that appears to connect Golgiderived membranes to the plasma membrane (20, 29). Following fusion of the transport
vesicle at the plasma membrane, viral particles are released and infection can start anew.
Because secondary envelopment and exocytosis are the last stages required to
produce infectious virions, upstream disruptions of replicative processes can manifest as
defects in envelopment or export. To increase replication efficiency, HCMV expresses
several miRNAs and viral proteins with overlapping functions. Some alter the host cell
metabolic profile and internal morphology while others participate in virion construction
and recruitment of essential components. This observed functional redundancy is one of
the primary cofounding factors to studying HCMV replication.
In this section, we explore the impact of virally induced mechanisms leading to
secondary envelopment and egress. Through understanding the cooperative nature of
viral and host-derived factors, we seek to outline a progressively more detailed map of
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these complex and often interwoven processes critical for virion maturation. Generation
of a map of HCMV replication enables identification of critical control points which can
then be exploited for the development of novel antiviral treatments.
A. Host-derived compartments as the site of secondary envelopment
Due to the dramatic restructuring of infected cells and the resultant shifts in
organelle identity (19), the source of membranes used for the process of envelopment is
unclear but correlations can be made using known cellular markers (23). Though it is not
strictly necessary, formation of the cytoplasmic virion assembly complex (cVAC) appears
to facilitate envelopment of nascent particles (21, 34).

Following the cVAC model,

nascent particles are enveloped during translocation through a Golgi-derived ring-like
structure and upon entrance into the predominantly endosomal-staining central
compartment (18, 19, 34).

Three-dimensional reconstruction of immune electron

micrographs (EMs) from infected human foreskin fibroblasts (HFFs) suggests that
envelopment likely occurs in a region coinciding with markers for both the trans-Golgi
Network (TGN) and various endosome populations as seen in other herpesviruses (19,
35-37).
Through immunofluorescence imaging and immunogold staining of EMs, it was
found that membranes targeted for envelopment based on glycoprotein accumulation
colocalize with typical Golgi-derived markers (TGN46, mannosidase II, Rab3, syntaxin 5)
and endosomal markers (CD63, EEA1, Rab11) but not lysosomal markers in HFFs (1720, 38-41). Supporting the role of endosomes in herpesvirus replication, HSV-1 or HCMV
infected cells labeled with horse radish peroxidase (HRP), a fluid phase marker of uptake
and release through the endocytic recycling compartment (ERC), had an accumulation of
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HRP in the interstitial space between the lipid bilayers of successfully enveloped particles
(42, 43). HRP accumulation is indicative of a change in the net flux of endocytic and
exocytic pathways throughout the ERC during infection. Transferrin receptor (TfR) also
appears to be sequestered in a perinuclear secretory trap coinciding with markers of the
cVAC (20).
Formation of the secretory trap is partly induced by HCMV miRNA-mediated
downregulation of recycling activity by targeting host genes involved in ERC trafficking
(44), a pattern also seen in Epstein-Barr virus (EBV) and Kaposi’s sarcoma-associated
herpesvirus (KSHV) (45, 46).

Characterization of the HCMV transcriptome late in

infection shows a much broader effect with 112 host vesicular trafficking genes being
differentially modulated by infection, far more than are targeted by miRNAs alone (44, 47,
48). This activity is multi-faceted because it both blocks innate immune signaling through
cytokines such as IL-6 or TNF-α and leads to the perinuclear pooling of virion
components, thus contributing to cVAC formation (44, 47, 49).
The immediate-early viral protein pUL37x1 also contributes to altered host
morphology and cVAC development by potentiating actin remodeling. pUL37x1 is a multifunction protein responsible for releasing Ca2+ stores from the endoplasmic reticulum
(ER) before traveling to mitochondria where it inhibits apoptosis (50-52). The Ca2+ efflux
activates PKCα which remodels actin along with RhoB (53), leading to altered
morphology. In addition, the efflux causes the accumulation of large cytoplasmic vesicles
approximately 0.5-5 µm in diameter through a process requiring FA synthesis and
elongation (50, 51, 54). When pUL37x1 is not expressed, the cVAC is disrupted and
there is an buildup of nonenveloped particles in the perinuclear region (51).
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It is not enough that the virion structural components are made in sufficient
quantities, they must also be spatially organized in the appropriate order. Only through
extensive rearrangement of host morphology, are virions efficiently produced.

The

complex orchestration of viral products and host factors underscores the complexity of
understanding virion envelopment.
B. Regulation of envelopment as a function of tegumentation
For envelopment to take place, one of several prerequisite steps that must be
completed is tegumentation.

The tegument layer of herpesvirus virions provides a

scaffold-like interface for membrane-associated viral proteins to adhere to during
envelopment. Because of this, alterations in tegument composition can ultimately cause
defective envelopment.
As an example, products of the UL35 ORF have been implicated as having a role
in tegument recruitment (55). At early time points, both ppUL35A and ppUL35 localize to
the nucleus where they interact with ppUL82 and activate the major IE promoter. At late
timepoints, however, the longer form, ppUL35, helps shuttle ppUL82 and pp65 (ppUL83)
out of the nucleus as it translocates to the cytoplasm for incorporation into the tegument
(55-58).

If the UL35 ORF is deleted, nonenveloped capsids accumulate in the

cytoplasmic space and infectious output is reduced 10-fold likely due to improper
tegument structure and inability to bind lipid recruiting molecules (55).
During infection, the tegument proteins pUL103 and pUL71 also contribute to the
process of envelopment (21, 59). pUL103 is required for cVAC biogenesis and efficient
release of nascent virions (21, 60, 61). Using the UL103-Stop-F/S deletion mutant or
UL103-FKBP destabilization mutant, decreased pUL103 expression correlated with
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altered trafficking of pp28 (viral UL99), golgin-97, GM130, and CD63 and decreased
plaque size (21, 60). Further imaging shows virions stalled during envelopment or with
abnormal structure accumulating in the perinuclear region (21). Because pUL103 has
several interacting partners during infection (22), it isn’t clear which process leads to the
observed phenotypes but it appears to be linked to the two C-terminal ALIX-binding
motifs. ALIX-binding motifs are also important in the maturation of other enveloped
viruses including during the primary envelopment of EBV (62-64). Alternatively, the
defective phenotypes may be linked to pUL103 interacting with pUL71 under normal
conditions (22, 65).
pUL71 is a component of mature virions and HCMV infected patients mount a B
cell response against it suggesting it may be exposed on virions or it is otherwise released
from host cells (58, 66). pUL71 deficient virus causes the aberrant localization of viral
proteins in the cVAC and the formation of large Lamp1/CD63 positive multi-vesicular
bodies (MVBs) near the cVAC in infected cells (59, 67). Structural analysis of the pUL71
null mutants, TBstop71 and BADinUL71STOP, showed the accumulation of HCMV
particles unable to complete envelopment on the cytoplasmic side of MVBs (59, 67).
During TBstop71 infection, 26.90% of particles were enveloped and 70.14% were
budding compared to 86.64% and 12.95%, respectively, during wild-type infection (68).
This behavior can be recapitulated when pUL71 is expressed with a mutated basic
leucine zipper (bZIP)-like domain suggesting oligomerization is necessary for pUL71 to
function properly (68, 69). Positional homologs of pUL71 are involved in envelopment
and are conserved amongst other herpesviruses including pUL51 in HSV-1 (70), UL51 in
pseudo-rabies virus (PRV) (71), and GP71 in guinea pig CMV (GPCMV) (72). The
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observed phenotypes of pUL71 suggest that it is involved in membrane scission events
during envelopment.
Despite being low abundance compared to other virion-associated proteins (58),
the outer tegument protein, pp28, is important for envelopment as well (73). After the
amino terminus of pp28 is myristoylated, it attaches to target membranes before localizing
to the cVAC and forming multimers late in infection (17, 39, 74, 75). When the first 50
residues at the amino terminus of pp28 are mutated, infectious yield is hindered due to
aberrant trafficking of pp28 and a corresponding accumulation of nonenveloped particles
in the cytoplasm (26, 76). The irregular trafficking of mutated pp28 does not affect the
level of other tegument proteins in mature virions suggesting it forms part of the outermost
layer of tegument proteins (26). Expression of only the amino-terminus of pp28 was
necessary and sufficient for reconstituting infectious output, accumulation of pp28 in
mature virions, and proper envelopment (76). Further characterization found the most
important sites of the pp28 amino terminus to be the second residue, glycine, which
serves as the site of myristoylation (39), amino acids (aa) 26-43 which are responsible
for multimerization in the cVAC (75), and aa 37-39 which allow interaction with the
cysteine residue at position 250 of the viral protein UL94 (77, 78). The ability of pp28 to
be incorporated in maturing virions is also dependent on its interaction with UL94 which
serves as a scaffold on the outside of the tegument (77, 78). Without UL94, secondary
envelopment and cVAC formation is hindered (79).

In HSV-1, KSHV, mouse

cytomegalovirus (MCMV), and murine herpesvirus 68 (MHV-68), homologs of pp28 and
UL94 play an analogous role but in contrast to HCMV infection, they are not considered
essential for virus replication (80-84).
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Genes within the HCMV UL/b’ region influence maturation through cell-specific
mechanisms. Within this region, the UL133-UL138 (UL133/8) locus is nonessential for
growth in fibroblasts but required for other cell types (85). Proteins produced by HCMV
UL135 and UL136 are transcribed as part of UL133/8 polycistronic mRNAs (86), localize
to Golgi membrane structures (87, 88), and are required for latency and virion maturation
(86, 88-93). UL135 and UL136 ORFs were responsible for the dispersion of cVAC
markers and abnormal particle formation when human lung microvascular endothelial
cells (HMVECs), but not fibroblasts, were infected with a TB40/E-UL133-UL138NULL virus
(88-91). Using a TB40/E-UL135STOP mutant defective in UL135 expression to infect
HMVECs, only 27% of virions exhibited normal morphology with the remainder being noninfectious enveloped particles (NIEPs) or aberrantly enveloped particles (90). UL135
mutation also resulted in smaller dense bodies, caused by a 2- to 3-fold decrease in pp65
and pp150 expression, and, furthermore, dense bodies were excluded from MVBs where
they normally aggregate with progeny virus in endothelial cells (89, 90). In fibroblasts,
the only phenotype of infection with TB40/E-UL135STOP was a slight increase in NIEPs
relative to wild type (91). Using similar methodology as the UL135 studies, a TB40/EUL136GalK mutant with a disrupted UL136 ORF produced aberrantly enveloped virions
65% of the time and dense bodies that were 2.5 times larger on average despite having
comparable levels of tegument proteins compared to wild type (90). Of the several
different sized proteins encoded by UL136 splice variants, the 26 kDa and 33 kDa
products were shown to be the most important in facilitating normal cVAC biogenesis and
particle formation (92, 93). Although specific mechanisms have yet to be determined,
HCMV pUL135 appears to direct maturation and envelopment through interactions with
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other tegument proteins while UL136 ORF isoforms are needed for interacting with target
membranes.

The endothelial-dependent phenotypes exhibited by UL133/8 locus

mutations are a prime example of the manipulative nature of HCMV in distinct host
environments.
The herpesvirus tegument serves essential functions during replication and
initiation of new infections.

During HCMV infection, the diverse, yet overlapping,

mechanisms of recruiting lipids demonstrate how important this function is to virion
replication.

Through their interactions between capsids and envelope-associated

glycoproteins, tegument proteins are responsible for bringing together the various
biosynthetic pathways and initiating secondary envelopment.
C. Outcomes of envelopment as determined by glycoprotein composition
The variability in cellular tropism of nascent virions from different cell types
suggests different maturation events occur leading up to egress. As in other
herpesviruses, including GPCMV and rhesus CMV (RhCMV), HCMV glycoprotein
composition plays a role in establishing sites of envelopment (94-100). HCMV isolates
contain approximately 70 ORFs with predicted features of glycoproteins but only a few
have been directly studied (95, 101, 102). The most abundant HCMV glycoproteins are
gM (UL100), gN (UL73), gB (UL55), gH (UL75), gL (UL115), gO (UL74), and UL128-131
(58) but most have not been detected in virions suggesting non-structural roles. The
gM/gN complex is the most abundant glycoprotein complex in mature HCMV virion
envelopes and if either is deleted, the virus is unable to replicate (103).
Similar to EBV (104, 105), gM and gN form a complex (gM/gN) when present in
the ER before they can be trafficked to cytoplasmic vesicles and colocalize with other
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markers of the cVAC (106, 107). Translocation of HCMV gM to the cVAC occurs when
the cytoplasmic region of gM interacts with cellular FIP4, FIP4 binds Rab11, and Rab11
recruits further effector proteins until gM is transported in complex with gN (108). gM and
gN also contain other C-terminal endocytic trafficking motifs, including an acidic cluster
used for binding cellular transport proteins, such as PACS-1, and a YXXΦ tyrosine motif
(109-111). The highly-conserved nature of the C-terminal acidic clusters in herpesvirus
glycoproteins suggests a common mechanism for direct transport to the site of virion
envelopment using membranes believed to be TGN-derived (112-116). YXXΦ motifs are
also conserved across all subfamilies of Herpesviridae and allow various envelope
proteins to be retrieved from the plasma membrane through interactions with the AP-2
complex

leading

to

clathrin-mediated,

dynamin-dependent,

endocytosis

and

accumulation in endosomes or the TGN (98, 117-120).
Cell-to-cell spread during HSV-1 infection is dependent on the UL51 (HCMV
pUL71 homolog)/gE (US8) interaction (121, 122), an important mediator of syncytia
formation (123, 124), before both are transported to the site of envelopment through use
of terminal YXXΦ tyrosine motifs (70, 122, 125-128). When the motif is mutated in pUL51,
neither pUL51 nor gE is incorporated into nascent virions and spread is hindered in Hep2 human epithelial cells but not Vero monkey epithelial cells suggesting cell type
dependent mechanisms for spread (122).
In HCMV, the more defined assembly compartment results in greater
concentration of envelope proteins compared to other herpesviruses. Inclusion of both
the acidic cluster and YXXΦ motifs in most envelope proteins ensures proper localization
to the assembly compartment. Neither trafficking pattern is essential for virus production
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but they both serve to augment infectious output as seen in HCMV gB, gM/gN, and
gpUL132 (109, 119, 129-132), varicella-zoster virus (VZV) gE, gH, and gB (99), HSV-1
gB, pUL51, and gE (98, 122, 133), or PRV gB (134), amongst others. During HSV-1
infection, UL20 helps chaperone gK and gE from the ER to Golgi and without it, neither
glycoprotein is incorporated resulting in accumulation of nonenveloped particles and
inability to form syncytia (135, 136).
The incorporation of gH/gL complexes into the envelope of nascent virions is
another example of maturation events defining HCMV tropism (137-140).

HCMV and

GPCMV virions require the gH/gL/gO complex for entering fibroblasts by fusion at the
plasma membrane and the gH/gL/UL128-131 pentameric complex for entry into epithelial
and endothelial cells by pH dependent endocytosis (24, 94, 96, 141). Some laboratory
strains are fibroblast-restricted because serial passaging has led to loss of functional
UL128-UL131 and a compensatory increase in gH/gL/gO concentration (142-144). The
ratio between gH/gL/gO and gH/gL/UL128-131 complexes is determined within the ER
prior to transport to Golgi or post-Golgi membranes for use in envelopment (96, 140, 145,
146). After gH and gL interact and stabilize each other in the ER (147), a single gH/gL
complex can either form a disulfide bond with gO or a noncovalent bond with UL128-131
but not both (96, 148). During formation of the pentameric complex, UL128, UL130, and
UL131 are each capable of binding to gH/gL and help recruit the remaining components
of the pentameric complex (96). To a lesser degree, the UL116 glycoprotein also appears
to compete for gH binding in the ER but its role is still unknown (149). Only after formation
of gH/gL/gO or gH/gL/UL128-131 do the complexes migrate to the Golgi where they
mature through glycosylation and become incorporated into virions (96, 145, 150).
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Glycoprotein complex formation and incorporation in HCMV infected cells is driven
by several viral proteins including US17, UL148, and gO (1, 151, 152). In addition to its
immune modulatory role, when the transmembrane protein US17 was deleted, gH was
mislocalized and there was a 3-fold decrease in the level of gH found in virions (1).
UL148 is a glycoprotein with a RXR motif that retains it in the ER where it appears
to bind and sequester gH/gL/UL130 or gH/gL/UL131 thus reducing the formation and
trafficking of completed gH/gL/UL128-131 complexes to the cVAC leading to an
enrichment of gH/gL/gO in virions (151). Using the TB40/E deletion strain TB_Δ148, high
MOI infections were similar to parent in HFFs but yielded 100x more infectious output in
ARPE-19 human retinal pigment epithelial cells (151).
substantially less gH/gL/gO complexes to form (151).

The deletion also caused
Insertion of UL148 into the

laboratory strain ADr131 which previously lacked it decreased ARPE-19 tropism four-fold
(151). A related tropism effect was seen when comparing B cell-derived to epithelial cellderived EBV suggesting mechanisms for selecting envelope glycoprotein complexes may
be a conserved feature of herpesviruses (147). Positional homologs of HCMV gO exhibit
approximately 40% aa similarity on average and are maintained in HHV-6A (U47), HHV6B (KA8L), HHV-7 (U47), and MCMV (M74) (153, 154). Binding properties of HCMV gO
vary in efficiency and are strain dependent (146). When aligning the aa sequences of
HCMV gO in 40 clinical and 6 laboratory strains, gO isoforms group into 8 different
families with increased diversity between sequences at aa 1-100 of the N-terminus and
residues in the 270-340 region (146, 155). While gO isoforms from HCMV strains Towne,
TR, Merlin, TB40/E, and AD169 were all able to form disulfide bonds with TR gH/gL in
HFFs, virions produced in the presence of Merlin gO incorporated significantly more
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gH/gL/UL128-131 than gH/gL/gO as opposed to the other strains in which the ratios were
reversed (146).

Infecting fibroblasts using strains without gO expression caused

accumulation of nonenveloped particles in the cytoplasm and mature virions had
increased levels of gH/gL/UL128-131 but 50% less gH/gL overall (143, 152).
Interestingly, when HUVECs were infected with a UL131 deletion mutant, an identical
phenotype was observed but virions accumulated increased levels of gH/gL/gO instead
emphasizing the cell specific pathways and competitive nature of glycoprotein complex
selection in virion maturation.
By altering glycoprotein expression during infection, HCMV is able to diversify the
spread of infection and avoid complete elimination from infected hosts. On a more basic
level than determining cellular tropisms, herpesvirus glycoproteins serve a crucial role as
bridges between the lipid membrane and tegument layer, without which, production of
infectious particles is severely diminished.
D. Fatty acid metabolism as a driver of envelopment
As part of the process that leads to cVAC formation, envelopment, and egress,
HCMV induces significant alterations in the metabolic profile of host cells (156). As
opposed to HSV-1 infection which upregulates pyrimidine nucleotide synthesis, HCMV
induces a metabolic shift that favors long chain FA synthesis (30, 156-158). By altering
the metabolic profile during infection, HCMV upregulates saturated FA, which increase
membrane curvature at sites of envelopment. As seen with other enveloped viruses,
increased curvature promotes envelopment through concentration of membrane-bound
viral proteins and decreased energy cost during membrane budding (159-162).
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The first committed step of FA acid synthesis is catalyzed by acetyl-CoA
carboxylase (ACC) generating malonyl-CoA from byproducts of glycolysis and the
tricarboxylic acid (TCA) cycle (163, 164). Malonyl-CoA is then used as a substrate by
cellular acyl-CoA synthetases and elongases to create long chain FA (LCFA; 14-21 C
chain) and very long chain FA (VLCFA; 21 < C chain) (163, 164).
Following HCMV infection, uptake of cellular glucose required for glycolysis was
increased as a downstream result of the antiviral protein viperin becoming activated (165167). Cellular ACC levels also increased coincident with HCMV infection. By increasing
glucose and ACC, host malonyl-CoA production capacity increases and drives
downstream FA synthesis. If this process is blocked as during inhibition of ACC by siRNA
or the inhibitor TOFA, virion output decreased by 10-100-fold ostensibly due to loss of FA
(157, 158).
In addition to viperin, infected cells also upregulate the plasma membrane-bound
low-density lipoprotein related receptor 1 (LRP1) as part of the antiviral response (28).
Offsetting the adipogenic outcome of viperin upregulation, LRP1 depletes cellular- and
virion-associated cholesterol because of amplified FA synthesis during infection.
Inhibition of LRP1 by siRNA or antibody binding was sufficient to increase cholesterol
concentration and infectivity of nascent virions (28).
An extensive siRNA screen identified 172 cellular enzymes associated with FA
metabolism and adipogenesis as having a role in HCMV replication (30). From the
screen, several acyl-CoA synthetases, including ACSM2A, 3-5, ACSBG1-2, ACSL1, 3-6,
and SLC27A1-6 plus the ELOVL1-7 family of elongases, were found to be important for
HCMV biogenesis (30). Pharmacological inhibition of either set of enzymes caused
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reduced viral infectivity with elongase inhibitors delaying expression of viral genes and
causing a reduction in overall abundance of the tegument protein pp28 (30). In addition
to acyl-CoA synthetases and elongases, class III phosphatidylinositol 3-kinase (Vps34)
was also identified in the screen as being required for growth; without it, nonenveloped
virions accumulate in the cytoplasm (30, 51).
During HCMV infection, Vps34 and ACC cooperatively form large cytoplasmic
vesicles, presumed to be the sites of virion envelopment, and act downstream of the viral
protein pUL37x1 in the process of envelopment (51). Through carbon labeling and mass
spectrometry, the increased acyl-CoA synthetase, elongase, and Vps34 expression were
found to cause an upregulation of saturated VLCFA in the viral envelope due to C18 FA
elongation, not de novo synthesis (30). Accumulation of VLCFA in defined regions is
associated with increased membrane curvature (162, 168-171). The lack of de novo
synthesis suggested HCMV uses preexisting stores of FAs to generate VLCFA for virion
envelopes. The source was later found to be lipid droplets within the host cell (30).
The ability to maintain elevated lipogenesis during HCMV infection is dependent
on cleavage of the cellular sterol regulatory element binding protein (SREBP) by SREBP
activation protein (SCAP) (172). Under normal conditions, the interaction of SREBP1 and
SCAP is inhibited by increased sterol formation but HCMV overrides the failsafe through
expression of pUL38 (31, 172). pUL38 removes a repressor of mTOR activity which is
sufficient for maintaining cleavage and activation of SREBP1 thereby inducing elongase
ELOVL7 and VLCFA is synthesized for use in virion envelopment (31, 173, 174).
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E. Completion of envelopment by membrane scission
After maturing virions have initiated the budding process, membrane scission
events are required to seal the envelope. In cellular pathways, scission is mediated by
dynamin- or endosomal sorting complex required for transport (ESCRT)-dependent
mechanisms (175, 176). Dynamin is required for pinching off membranes during inbound
trafficking and ESCRT stitches membranes closed as they bud into topologically
extracellular vacuoles within cells as seen in MVB formation. While both are used for
replication of enveloped viruses (177-179), the propensity for HCMV virions to
accumulate in structures resembling MVBs suggests a dependence on ESCRT-mediated
pathways (67, 90, 175, 176).
ESCRT machinery is comprised of five main cytoplasmic complexes, ESCRT-0, I, -II, III, and Vps4-Vta1, and assists in both budding and scission of cellular vesicles
through recognition of ubiquitin signals (175, 180-182).

There is some conflicting

evidence but ESCRT-0, -I, and -II appear to act in parallel, not sequentially, to facilitate
budding (175, 180-182).

ESCRT-III and Vps4-Vta1 act downstream of the other

complexes and control the scission and release events, respectively (175, 176).
Following cVAC formation during HCMV infection, components of the ESCRT
machinery are intermingled with Golgi and endosomal markers near sites of envelopment
(19, 183). During infection of RPE1 retinal pigment epithelial cells with a GFP labelled
variant of AD169, siRNA silencing of Tsg101, a component of ESCRT-I, and Alix, which
helps recruit ESCRT-III, did not reduce virion output (184). Conversely, siRNA silencing
of Vps4A/B resulted in increased infectious output suggesting ESCRT recruitment was
nonessential and, in some cases, inhibitory to virion maturation (184). In a separate
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study, HFFs were infected with the HCMV strain Towne followed by transfection with
dominant negative (DN) forms of Vps4, Tsg101, and CHMP1, a component of ESCRT-III
(183). CHMP1DN and Vps4DN reduced infectious output in contrast to the previous study
(183).
Results from both studies combined with other observations suggest that HCMV
utilizes ESCRT machinery for membrane budding and scission but may have functional
redundancies that allow it to bypass requirements for recruitment of upstream ESCRT
complexes (67, 90, 183, 184).

For example, HCMV UL103 contains ALIX binding

domains so through interactions with other tegument proteins, including membrane
associated pUL71, and ALIX, UL103 may be able to recruit ESCRT-III to membranes for
envelopment without involving ESCRT-0, -I, or -II (21, 22, 59, 65, 67). Another possible
explanation for the discordant results is ESCRT complexes are multi-protein formations
so only targeting select proteins may not be enough to abrogate budding and scission.
As a potential confounding variable, the studies were conducted in different cell types
with strains containing divergent coding potential so the results may indicate nuanced
differences in virion maturation.
What is known is that other herpesviruses also utilize ESCRT functions for
envelopment which suggests this may be a conserved mechanism for viruses within
Herpesviridae. HSV-1 and HHV-6 particle envelopment is dependent on MVB formation
and HSV-1 utilizes a Vps4-dependent mechanism (185-188), however, it is independent
of Tsg101 and ALIX similar to HCMV (189). Alternatively, the observed defects following
targeting of ESCRT machinery may be related to events required for entry into cells, as
seen during KSHV infection (190-192), or membrane remodeling as seen with EBV (64).
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F. Virion egress completes HCMV replication
Following successful envelopment, fully matured virions must be exported out of
host cells. For herpesviruses, HCMV in particular, the mechanism of viral egress is poorly
understood.
In vesicle-mediated transport, divergent pathways maintain unique lipid and
protein signatures because the concentration of various FA moieties in a given region
defines membrane physiology and restricts the array of interacting proteins (193-196).
By analyzing the lipid composition of mature virions, correlations can be made with known
trafficking pathways and exocytic events can be better understood.
To identify potential pathways, liquid chromatography-mass spectrometry (LC-MS)
was used analyze the lipidome of HCMV infected fibroblasts by measuring the relative
abundance of 146 unique glycerophospholipid (GPL) species with chain lengths of 30-42
carbons (29). Except for a four-fold enrichment of phosphatidic acid (PA) during infection,
the cellular GPL profile did not deviate greatly from mock-infected cells (29). The GPL
composition of virions, however, was markedly different compared to HCMV- or mockinfected

cells

and

was

dominated

by

phosphatidylcholine

(PC)

and

phosphatidylethanolamine (PE) species (29). When compared to known subcellular
compartments, the lipid composition of virion envelopes most closely matched profiles
seen in neuronal synaptic vesicle membranes suggesting HCMV particles follow a related
secretory vesicle (SV) pathway that operates in non-neuronal cells (29).
Secretion via SVs is dependent on a highly-conserved trafficking pipeline used in
cells from diverse lineages including mast cells in the immune system and β cells in the
pancreas (197-201). Usage of such a widely available pathway would potentially enable
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infection of diverse cell types as seen during HCMV infection. Assuming this is the same
pathway HCMV uses, it would dramatically reduce the coding potential required to
facilitate release in the functionally disparate group of cell types subject to HCMV infection
in vivo.

Starting at the TGN, SV release is mediated by several factors acting in

sequence. Various Rab GTPases, cytoskeletal motors, and SNAP/SNARE complexes
associate with the target vesicle and relay it towards the plasma membrane where fusion
occurs by a Ca2+ dependent mechanism (202-207).
Several proteins involved in SV transport have been implicated in exocytosis of
HCMV and other herpesviruses.

Rab GTPases control specific vesicle-mediated

trafficking events within cells (208, 209). For SV exocytosis, Rab3 and Rab27 work
cooperatively to transport and dock vesicles at the plasma membrane prior to fusion (201,
210, 211).

Maturing HCMV and HSV-1 virions associate with Rab3 containing

membranes following immunogold staining and EM imaging (38, 212).

Likewise,

infectious output was dramatically reduced in Rab27A deficient cells when infected with
HCMV and HSV-1 (33, 213).
Once docked at the plasma membrane, SVs require SNAP/SNARE complexes to
mediate fusion. Syntaxin 3 (STX3) is one of several SNARE proteins capable of initiating
SV-plasma membrane fusion events (214). During HCMV infection, STX3 expression is
highly upregulated and localizes to the cVAC. When knocked down using shRNA,
production of infectious material was reduced four-fold (32). In neurons, SNAP25 is the
major SNAP protein involved in SNAP/SNARE-mediated SV exocytosis (204, 207). In
other cell types including fibroblasts, SNAP23, a homolog of SNAP25, is more widely
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used for exocytic events. SNAP23 abundance was unaffected by HCMV infection but
shRNA knockdown of SNAP23 decreased infectious output 1,000-fold (29).
There are several lines of evidence that predict HCMV uses a SV-like pathway for
final egress but it is noteworthy that inhibition of key proteins was not sufficient to
completely eliminate HCMV egress. This suggests either there are alternative pathways
for virion egress or the SV pathway may only be important for one aspect of virion
replication not necessarily specific to egress. For example, despite correlations with a
SV pathway, HSV-1 and PRV infectious particles in neurons associate with and are
released

via

a

Rab6A/Rab8A/Rab11A-dependent

pathway

as

opposed

to

Rab3A/Rab27A-staining vesicles (212, 215-217). The difference in HSV-1 and PRV
function may a result of increased cellular dependence for Rab3A/Rab27A pathways
during maintenance of homeostasis compared to other cell types.
III. This Work
Complications from HCMV infection place a high burden on society due to their
frequency and severity.

An effective vaccine has yet to be developed and current

treatments are limited in target diversity due to a lack of understanding of HCMV
replicative processes.

By exploring the cellular-associated aspects of HCMV

envelopment and egress, we aim to build a map of maturing HCMV virions as they
traverse the cytoplasmic assembly compartment.
To accomplish this, I will first describe the structure and function of a novel HCMV
transduction vector, TB40/E/Cre, for use in studying various genes of interest in the
context of infection. Through demonstration of its growth properties, we were able to
make preliminary observations relating HCMV genome length to replicative efficiency in
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fibroblasts. Using various protein tags, we also show the utility of expressing genes from
TB40/E/Cre. The flexibility of TB40/E/Cre allows it to be adapted to a wide range of
experiments such as studying cellular trafficking pathways.
Next, I transition into our current model of pathways involved in HCMV assembly
and egress. By analyzing previously generated microarray data (1), we were able to
identify clusters of cellular transcripts significantly altered over the course of infection that
have defined roles in host vesicle mediated transport. By mapping the transcriptional
data onto known pathways, we establish a model for which transport events are favored
during HCMV virion maturation.
Lastly, I will summarize the contributions made to herpesvirus biology as part of
this work. Inherent to that is the current state of knowledge and the potential for future
directions. Through our work, we have developed various tools and models that will
continue to benefit researchers going forward. By applying these concepts to HCMV
replication, we have generated a road map of HCMV maturation as virions navigate
through host compartments.
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Fig. 1.1. Structure of an HCMV virion. An artist representation and an electron micrograph image of an
HCMV virion are shown with the corresponding layers.
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Fig. 1.2. Comparative alignment of herpesvirus genomes demonstrates conserved regions and strainspecific differences. Small triangles depict virally encoded open reading frames (ORFs), boxes represent
repeat regions, and colored boxes denote conserved gene blocks. Abbreviations: herpes simplex virus 1
(HSV-1), herpes simplex virus 2 (HSV-2), varicella zoster virus (VZV), human cytomegalovirus (HCMV),
human herpesvirus 7 (HHV-7), Epstein-Barr virus (EBV), human herpesvirus 8 (HHV-8)
Figure adapted, with permission, from P.E. Pellett and B. Roizman, Fields Virology, 6th ed., 2013, p 1802-1822
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Fig. 1.3. General replication cycle of herpesviruses. (A) Adherence, entry, and initiation of infection.
Extracellular virions adhere to target host cells; the capsid and tegument are released following fusion at the
plasma membrane or within endocytic vesicles; the viral genome is delivered to the nucleus and immediate
early (IE, α) transcripts are expressed or latency is induced. (B) Early (E, β) protein expression leads to DNA
replication of the viral genome and late (L, γ) gene expression. (C) Herpesvirus assembly. Structural L proteins
assemble into the capsid prior to genome packaging and nuclear export. Viruses follow two general pathways:
a) capsids associate with nuclear tegument proteins and bud through the nuclear membrane, thereby
becoming enveloped, before final exocytosis or b) capsids are exported to the cytoplasm where they acquire
the tegument and host-derived envelope prior to being exported from host cells.
Figure adapted, with permission, from P.E. Pellett and B. Roizman, Fields Virology, 6th ed., 2013, p 1802-1822
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Fig. 1.4. Three-dimensional structure of the HCMV cytoplasmic virion assembly complex (cVAC).
Immunofluorescence imaging shows the characteristic reniform nuclei (DAPI) surrounding the ring-like Golgi
structure (mannosidase II) with endosome populations at the center (EEA1)
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CHAPTER 2: GENERATION OF A NOVEL HUMAN CYTOMEGALOVIRUS BACTERIAL
ARTIFICIAL CHROMOSOME, TB40/E/CRE, TAILORED FOR TRANSDUCTION OF
EXOGENOUS SEQUENCES
I. Abstract
The study of herpesviruses, including human cytomegalovirus (HCMV), is
complicated by viral genome complexity and inefficient methods for genetic manipulation
in tissue culture. To facilitate reverse genetics of herpesvirus genomes, isolates have
been adapted to grow in E. coli as bacterial artificial chromosomes (BACs). Through BAC
adaption, viral genomes are easily manipulated using bacterial recombinational systems.
Strict herpesvirus genome packaging requirements require deletion of viral genes
for inclusion of the E. coli mini-F propagation sequence. Contextual classification of
deleted regions as nonessential for growth reduces biological significance due to loss of
potentially important uncharacterized functions. To avoid deleting viral genes, several
BACs utilize a Cre/LoxP system to self-excise the mini-F sequence upon reconstitution
of virus in tissue culture.
Here, we describe the adaptation of Cre/LoxP to modify the mini-F sequence of
the HCMV BAC, TB40/E, thus generating a new self-excisable BAC, TB40/E/Cre. By
excising the E. coli propagation sequence, an approximately 2.7 kbp genome length
deficit is created due to a preexisting deletion within the US2-US6 coding region. We
exploit this deficit to incorporate genes of interest fused to an FKBP destabilization
domain thereby creating a novel gene transduction system for studying exogenous
proteins during HCMV infection. Using TB40/E/Cre, we found genome length-associated
differences in growth and demonstrated its utility as a transduction system by significantly
regulating the accumulation of an exogenously expressed cellular protein within 2 h.
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Because of its flexibility, TB40/E/Cre is a powerful tool that can be adapted to study HCMV
replication in a variety of contexts. The work presented in this chapter has been submitted
for publication pending review.
II. Introduction
Human cytomegalovirus (HCMV) is a double-stranded DNA virus belonging to the
family Herpesviridae. HCMV is abundant in the population but only causes minor illness
in children and adults with functionally mature immune systems. For those with naïve or
compromised immune systems, such as developing fetuses, AIDS patients, or transplant
recipients, HCMV infection is associated with several manifestations including hearing
loss, gastric ulcers, blindness, liver failure, and encephalitis (9, 218, 219). HCMV is also
the leading infectious cause of congenital birth defects and the major non-genetic cause
of early-life hearing loss (220, 221). Despite its associated public health impact, HCMV
replication is poorly understood when compared to viruses such as HIV and Hepatitis C
(222-224). The complexity of herpesvirus genomes greatly contributes to the difficulty of
studying their replication. Herpesvirus genomes are 130-240 kbp in size with some
containing invertible unique short (US) and unique long (UL) regions (225). HCMV
contains the largest known herpesvirus genome at 230-240 kbp which encodes at least
200 protein open reading frames (ORFs) and 14 miRNAs (48, 101, 144, 226, 227). While
reverse genetics facilitates the exploration of viral gene function, systems for genetic
manipulation of herpes genomes in mammalian cell culture are difficult, time-consuming,
and inefficient (228, 229).
Bacterial artificial chromosomes (BACs) allow the high-fidelity propagation of
sequences of up to 300 kbp in Escherichia coli (E. coli) (230, 231). Strains of several
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HCMV isolates have been adapted as BACs allowing the use of bacterial systems for
mutation of viral sequences before reconstitution and functional analysis of virus in
mammalian cells (232-236). New BACs are generated by infecting mammalian cells with
viral isolates in the presence of constructs containing a selectable E. coli mini-F
propagation sequence flanked by viral targeting sequences (234, 237-240).

Host-

mediated homologous recombination between the HCMV genome and viral targeting
sequences leads to the incorporation of the mini-F sequence into the HCMV genome.
Following selection (236, 239), recombined genomes are purified and transformed into E.
coli where they replicate as plasmids and can be further manipulated by recombinational
processes (235, 241, 242).
Similar to some classes of tailed bacteriophage, herpesviruses have strict genome
length packaging restrictions (225, 243). Because of this, generation of new HCMV BACs
has relied on deletion of sufficient viral sequences to accommodate the E. coli mini-F
sequence (85, 234, 244, 245). In the HCMV BAC strains TR-BAC (TR) and TB40/E BAC
clone 4 (TB40/E), the mini-F sequence is substituted into the US2-US6 locus and is
maintained in the viral genome after virus reconstitution in mammalian cells (85, 244).
This poses two major problems: i) intentional deletion of US2-US6 or other viral coding
regions assumes the genes are nonessential, a term which is contextually defined by the
experiment and ii) the E. coli mini-F sequence insertion is generally larger than the region
being replaced thereby increasing genome length and potentially interfering with
herpesvirus packaging.
Under normal conditions, rolling-circle replication of herpesvirus genomes
produces viral genome concatemers (225, 246-248). Viral genomes are inserted into
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capsids by the viral terminase complex and an ATP-dependent mechanism until the
capsid has reached a structurally defined capacity (249). After passing the capacity
threshold, a conformational signal is initiated and terminase subunits cleave the
concatemers at designated pac sites found within the US and UL inverted terminal repeat
regions (225, 249-254). The result is a rigid highly pressurized capsid containing one full
complement of the herpesvirus genome (225, 255, 256). If the genome is too short,
nascent particles are less infectious possibly due to loss of important genes or a decrease
in internal pressure required for injection of the genome into host nuclei upon infection. If
the genome is too long, the physiological capacity of the capsid is exceeded and
incomplete genomes are packaged or spontaneous deletions are used to compensate.
As an example, reconstitution and production of infectious guinea pig cytomegalovirus
(GPCMV) virions was reduced when the 233 kbp genome length was decreased by more
than 6.5% following deletion of nonessential genes or increased by 3.8% following
insertion of an 8.8 kbp E. coli mini-F sequence (257). Insertion of the E. coli propagation
sequence was also correlated with deletion of several-kbp-long regions elsewhere in the
genome (257, 258). Likewise, sequence analysis of TR found deletions from US9-US16
and analysis of TB40/E found spontaneous excision of the remaining portion of US2
through US9, including the E. coli mini-F sequence (259).

These observations are

consistent with genome size being important for production of nascent virus.
Alternatively, other herpesvirus BACs utilize a Cre/Lox system for excision of the
E. coli propagation sequence following reintroduction to mammalian cells (238, 258, 260,
261).

E. coli mini-F sequence excision avoids maintenance of length increases in

reconstituted virus and mitigates the need for spontaneous mutation as evidenced by the
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absence of large-scale deletions in the Cre/Lox-containing Merlin-BAC (Merlin) compared
to TR or TB40/E (238, 259). In self-excisable BACs, such as Merlin or the AD169 adapted
strain, pAD/Cre, a copy of the Cre recombinase gene containing a synthetic intron (inCre)
is inserted adjacent to the E. coli mini-F sequence and both are flanked by LoxP sites
(239, 262). In bacterial culture, inCre remains inactive but introduction to mammalian
cells causes splicing and activation of inCre leading to excision of the E. coli propagation
sequence (261).
To address the problem of studying genes of interest during infection, we adapted
the Cre/Lox system to generate a novel TB40/E-derived self-excisable HCMV BAC,
TB40/E/Cre, for the transduction of exogenous sequences. TB40/E was chosen as a
template based on preserved endothelial and epithelial cell tropisms compared to other
HCMV laboratory strains (85, 244). Relative to a virus with an intact US2-US6 region, an
approximately 2.7 kbp genome length deficit is created following BAC excision. We use
the resultant genome length availability to transduce proteins of interest. This new
construct: i) alleviates length-associated selective pressures (259), ii) removes the need
for deletion of other viral sequences (245, 263), and iii) maintains comparability to
previous studies. As a demonstration of its utility, we use TB40/E/Cre to express the
cellular trafficking protein Rab3A tagged with the ECFP fluorescent protein and FKBP
destabilization domain (264).

In this study, we show the power of the TB40/E/Cre

transduction system through the controlled accumulation and visualization of Rab3A
within the HCMV assembly compartment. In addition to its use as a vector, we used
TB40/E/Cre to conduct a preliminary study directly relating HCMV genome size to growth
in tissue culture. HCMV strains with genome lengths most similar to wild-type (WT)
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isolates had modest growth advantages compared to strains containing extraneous
insertions. The ability to adapt TB40/E/Cre for use in various experimental contexts
makes it a powerful tool for understanding critical components of HCMV replication and
herpesvirus biology as a whole.
III. Materials and Methods
A. Cells and virus.
HCMV strain TB40/E BAC clone 4 was generously provided by Christian Sinzger
(University of Tubingen, Germany) and strain pAD/Cre was kindly provided by Dong Yu
(Washington University, St. Louis, MO) (239, 244). Viruses were grown in low-passagenumber pooled human foreskin fibroblasts (HFFs) in complete Dulbecco’s modified Eagle
medium (DMEM; Hyclone, Logan, UT; catalog no. SH30243.01) supplemented with 1%
nonessential amino acids (Hyclone, Logan, UT; catalog no. SH30238.01), 1% GlutaMax
(Gibco, Gaithersburg, MD; catalog no. 35050-061), and 5-10% fetal bovine serum (FBS;
Atlanta Biologicals, Atlanta, GA; catalog no. S11150). Virus was titrated by standard
plaque assay in HFFs.
BAC recombineering was done in the Escherichia coli (E. coli) strains SW102 and
SW105, provided by Donald L. Court (National Cancer Institute, Bethesda, MD) (235).
SW102 contains a heat-inducible lambda phage Red recombinase gene and is unable to
utilize galactose due to a galK deletion. SW105 also contains temperature-sensitive Red
recombinase and galK deletion in addition to a gene for arabinose-inducible flippase.
B. Electrocompetency and recombinase induction.
E. coli strain overnights were grown in Luria broth (LB) with appropriate antibiotic
selection on a 32°C shaking incubator. The next day, a 1/50 dilution of the culture was
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made in antibiotic-LB until an OD600 of 0.5-0.7 was reached. Cells were spun down at
4°C at 4,500 x g for 5 min and washed three times with ice cold sterile deionized water
(diH2O) or 10% glycerol in diH2O before being resuspended in a minimal amount of cold
diH2O or glycerol solution and aliquoted into separate tubes for electroporation or storage
at -80°C. To induce recombinase expression, SW102 and SW105 cells were transferred
to a shaking 42°C water bath for 15 min after reaching the appropriate OD600 and before
pelleting in the cooled centrifuge.

Following heat shock, the normal protocol was

resumed. If frozen, induced cells were used within 48 h. Uninduced cells were used as
a control for transformation and recombination efficiency.
C. Construction of recombinant viruses.
Recombineering of HCMV BACs was done as previously described (21, 235). In
brief, competent E. coli SW102/SW105 cells were electroporated with BAC DNA and
selected for by growth on chloramphenicol (Cam)-LB plates. Fragments with a galK/kanr
selection cassette were PCR amplified from pYD-C630 (provided by Dong Yu) with
primers containing 50 bp of overhang homologous for the desired region of insertion into
the BAC (Table 2.1, Fig. 2.1 and 2.6).

The galK/kanr containing amplicons were

electroporated into competent and Red recombinase-induced E. coli SW102/SW105 cells
before plating on kanamycin (Kan)/Cam-GalK indicator plates (MacConkey agar base
with 5% D-galactose) for positive selection and screening of colonies.

Following

incubation at 32°C for two days, colonies were selected based on growth, indicating
incorporation of selection cassette into the BAC, and screened based on acid production
denoting galactose utilization. Colonies were restreaked onto a second Kan/Cam-GalK
indicator plate and grown overnight at 32°C. Following isolation of BAC DNA from
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candidate clones, selection cassette insertion was verified by PCR amplification across
cloning site junctions and size determination using 0.8% agarose gels in TBE buffer (89
mM Tris [pH7.6], 89 mM boric acid, 2 mM EDTA). Then, fragments containing desired
coding sequences were PCR amplified using primers with 50 bp of overhang homologous
to those used for insertion of the selection cassette (Table 2.1). These fragments were
electroporated into the previously verified galK/kanr-containing clones following induction
of the Red recombinase and cultures were grown for 4 h on a 32°C shaking incubator
prior. Outgrowths were washed 2x with 1x M9 salts, plated on media containing 2deoxygalactose (2-DOG; Acros Organics, Geel, Belgium; catalog no. 111970050; 1.5 %
agar, 1x M63, 0.2 % glycerol, 15 µg/ml Cam, 1 mM MgSO4, 0.2 % 2-DOG, 1 µg/ml biotin,
and 45 µg/ml leucine), a bacteriostatic galactose analog, and galK/kanr-containing
transformants were negatively selected. After growth at 32°C for five days, colonies were
streaked for isolation on Cam-GalK plates and grown overnight at 32°C. DNA was
isolated from individual colonies, inserts were PCR verified as before, and amplicons
were sent in for Sanger sequencing (Genewiz, South Plainfield, NJ). Isolated BAC DNA
was also restriction digested and proper band patterns were verified for each clone (see
corresponding section below).

Following verification, the process was repeated as

needed. For the induction of flippase in SW105 cells, 0.1% L-arabinose was added to
SW105 cultures in LB and incubated while shaking at 32°C for 1 h. Cells were diluted
1:10 and incubation was resumed for 4-5 h. Cultures were then washed 2x with 1x M9
salts and plated on Cam-GalK indicator plates before incubation overnight at 32°C.
Following completion of recombineering, large volume BAC DNA preps were made. For
reconstitution of virus, 2 µg of DNA were transfected into 80% confluent HFFs in a T25
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(4.4 x 104 cells/cm2) using Lipofectamine 2000 (ThermoFisher, Waltham, MA; catalog no.
11668027) and cells were grown in 10% FBS media until 100% cytopathic effects (CPE)
were observed. Infections were harvested and stocks were made for storage at -80°C
until use. Construction schematics are shown in Fig. 2.1 and 2.6; the primers are listed
in Table 2.1.
D. Restriction endonuclease analysis of BAC and reconstituted virus DNA.
Before transfection BAC DNA samples were purified from SW102 overnights using
a Plasmid Midi Kit (Qiagen, Valencia, CA; catalog no. 12143). For reconstituted viruses,
T175 flasks of HFFs were transfected with 2 µg of BAC DNA using Lipofectamine 2000
and grown until 100% CPE were evident. Flask contents were scraped, sonicated, and
spun at 3,000 x g for 5 min. The supernatant was then layered onto a 20% sorbitol
cushion and spun at 100,000 x g for 1 h at 4°C.

The virus-containing pellet was

resuspended in TNE buffer (10 mM Tris, 1 mM EDTA, 0.1 M NaCl, pH 7.4), treated with
DNase I (Promega, Madison, WI; catalog no. M6101), and DNA was isolated using a
Blood and Cell Culture DNA Mini Kit (Qiagen, Valencia, CA; catalog no. 13323).
Equivalent levels of BAC DNA from before transfection and after transfection were
digested using HindIII-HF and EcoRI-HF (New England Biolabs, Ipswich, MA; catalog
nos. R3104T and R3101T) for 1 h at 37°C and separated overnight using a large format
0.5% agarose gel in TBE buffer.
E. Virus growth curves.
HFFs were seeded at 1.67 x 105 cells per well in 12-well plates with 10% FBS
media. The following day, plates were infected at a multiplicity of infection (MOI) of 0.01
or 1.0 in 10% FBS media, incubated for 1-2 h at 37°C, washed with PBS (HyClone, Logan,
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UT; catalog no. SH30028.02), and replenished with clean 10% media. Plates were
incubated until noted time points at which time they were taken out and processed. For
extracellular samples, supernatants were removed and clarified by centrifugation at 1,500
x g and 4°C for 2 min. For intracellular samples, remaining cells were washed once with
PBS, fresh 10% FBS media was added, cells were scraped, transferred to a tube, and
then sonicated. Following sonication, the samples were spun as before and the pellets
were discarded. Virus titers were measured by plaque assay in 24-well plates.
F. Virus genome abundance.
Intracellular and extracellular samples from the viral growth curves were treated
with DNase I (Promega, Madison, WI; catalog no. M6101) for 30 min at 37°C prior to DNA
isolation using a QIAamp MinElute Virus Spin Kit (Qiagen, Valencia, CA; catalog no.
57704). Samples were assayed by quantitative PCR (qPCR) using iTaq Universal SYBR
Green Supermix (Bio-Rad, Hercules, CA; catalog no. 1725121), primers targeting HCMV
UL83, and 40 cycles on a 7500 Real-Time PCR System (Applied Biosystems, Foster City,
CA; catalog no. 4351105). Relative abundance was normalized relative to the TB40/E
day 3 sample in each set using the 2-ΔC’T method (3).
G. Immunoblots.
HFFs were grown to confluency and infected with HCMV strains at an MOI of 0.1
or 1.0 in 10% FBS media. Following 1-2 h incubation at 37°C, cells were washed once
with PBS, and clean 10% FBS media was added. For Shield-1 experiments, Shield-1
(Cheminpharma, Farmington, CT; catalog no. CIP-AS1) was added to a final
concentration of 1 µM at the desired times. At 96 hours post infection (hpi), cells were
washed with PBS and lysed using RIPA buffer (0.1 M HEPES [pH 7.4], 0.1% sodium
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deoxycholate, 150 mM NaCl, 1% NP-40, 0.1% SDS, and 1x EDTA-free protease
inhibitors [Roche, Basel, Switzerland; catalog no. 11836170001]). Lysates were passed
through a 27-gauge needle and centrifuged at 14,000 x g and 4°C for 10 min. Proteincontaining supernatants were collected for analysis.

Protein concentrations were

calculated using a bicinchoninic acid (BCA) kit (ThermoFisher, Waltham, MA; catalog no.
23227). Equal amounts of protein were added to 10x sample buffer (65% sucrose, 1%
Tris-HCl [pH 7.4], 10 mM EDTA, and 0.3% bromophenol blue) with 5% 2mercaptoethanol, incubated for 7 min at 100°C, and separated in 12% SDSpolyacrylamide gels before being transferred to nitrocellulose membrane (GE Healthcare,
New York, NY; catalog no. 10600007). Membranes were probed with primary antibodies
(see Table 2.2) and HRP-conjugated goat anti-mouse/rabbit IgG secondary antibodies
(Table 2.2; ThermoFisher, Waltham, MA). Reactive proteins were visualized by reaction
with Supersignal West Pico Chemiluminescent substrate (ThermoFisher, Waltham, MA;
catalog no. 34080) and exposure to autoradiography film (MIDSCI, St. Louis, MO; catalog
no. BX810). Relative protein levels were determined using densitometry and FIJI imaging
software (265).
H. Immunofluorescence assays (IFA).
Eight-well chamber slides (LabTek, Nunc, Rochester, NY; catalog no. 177-402)
were coated with 0.2% gelatin phosphate buffered saline (PBS) solution for 1 h at 37°C.
Following splitting and resuspension in 5% FBS media, HFF were seeded at 2.64 x 104
per well and incubated at 37°C. The following day, cells were infected at a multiplicity of
infection (MOI) of 0.1 in 5% FBS media and incubated at 37°C for 1-2 h. Cells were
washed once with warmed PBS before addition of clean 5% FBS media and continued
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incubation for 96 h. For Shield-1 experiments, the compound was added to a final
concentration of 1 µM at desired times. At 96 hpi, cells were fixed for 15 min using 4%
paraformaldehyde in PBS at pH 7.4 and autofluorescence was quenched by exposing
cells to 50 mM ammonium chloride in PBS for 15 min. Cells were then permeabilized for
15-20 min by exposure to 0.2% Triton X-100 in blocking buffer (5% glycine, 10% normal
goat serum, and 0.1% sodium azide in PBS) before incubation with blocking buffer for 1
h. Primary antibodies were diluted in blocking buffer before addition to the slide for 1 h
at 25°C. Slides were washed three times in PBS prior to incubation with secondary
antibodies (Table 2.2) for 1 h at 25°C. Following another series of PBS washes, slides
were mounted with Vectashield containing DAPI (4’,6-diamidino-2-phenylindole; Vector
Laboratories Inc., CA; catalog no. H-1200) and then sealed. Imaging was done using a
Nikon Eclipse E800 epi-fluorescence microscope system equipped with a 1.4 MP
monochromatic CoolSNAP ES2 CCD camera (Photometrics, Tucson, AZ) and
MetaMorph software (Molecular Devices, LLC., Sunnyvale, CA). False coloring of images
was done using FIJI (265).
IV. Results
A. Generation of TB40/E derived strains.
Our primary goal was to develop an HCMV BAC capable of accommodating
exogenous sequences to be used to manipulate cellular processes in infected cells. To
avoid genome size packaging restrictions without deleting viral sequences, we modified
the original TB40/E BAC by making the E. coli propagation sequence self-excisable. To
accomplish this, we modelled our new BAC, TB40/E/Cre, after the HCMV AD169-derived
BAC strain, pAD/Cre (239).
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Adaptation of the TB40/E E. coli propagation sequence required the incorporation
of Cre recombinase, a pair of associated LoxP cleavage sites, and an accessory linker
region (LR) (Fig. 2.1). BAC recombineering was used to systematically construct the new
BAC through alternating cycles of positive and negative selection using a galK/kanr
selection cassette and homologous recombination (235). The selection cassette was
cloned from the plasmid pYD-C630 and initially targeted to the junction of the truncated
US2 (trUS2) open reading frame (ORF) and adjacent E. coli mini-F sequence. Following
successful rounds of transformation and recombination in E. coli SW102 cells, TB40/E
US2 GalK/Kanr (TB40/E GalK/Kanr) was generated (BAC 2, Fig. 2.1). An upstream LoxP
fragment was then generated using overlapping primer pairs and inserted in place of the
selection cassette using a similar method as before (BAC 3, Fig. 2.1). The process was
repeated and a fragment containing the LR and CMV major immediate early (MIE)
enhancer (MIEEnh) was inserted following amplification from the plasmid pECFP-C1
Rab11A (BAC 5, Fig. 2.1). The LR is a 50 bp region of innocuous sequence directly
upstream of the MIEEnh without any significant degree of homology to known HCMV
sequences. It assists in targeting of amplicons during homologous recombination and
mitigates issues related to recombination of the LoxP sites during sequence insertion or
deletion. Next, the downstream LoxP site was cloned from pAD/Cre as part of a fragment
that included a SV40 promoter (SV40P)-driven cre gene. The presence of a synthetic
intron interrupting cre prevents proper expression of Cre until after transfection into
mammalian cells (262). After insertion of another selection cassette, the SV40P/cre-LoxP
fragment was inserted while oriented downstream of the E. coli mini-F sequence so both
cre and the E. coli propagation sequence would be within the bounds of the LoxP
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cleavage sites (BAC 7, Fig. 2.1). Finally, the galK/kanr selection cassette was inserted to
remove the MIEEnh and then subsequently deleted thus generating TB40/E/Cre GalK/Kanr
and TB40/E/Cre, respectively (BAC 8 and 9, Fig. 2.1). Proper insertion of the various
fragments was confirmed at each step by PCR amplification and sequencing of junctions,
as well as by assessing the overall integrity of the constructs by restriction endonuclease
digestion of the whole BAC plasmid (data not shown).
To verify the proper excision of the E. coli propagation sequence following
recombineering and reconstitution in mammalian cells, restriction mapping of TB40/E/Cre
was compared to TB40/E, TB40/E GalK/Kanr, and TB40/E/Cre GalK/Kanr both before and
after transfection (Fig. 2.2). By monitoring the presence or absence of predicted bands,
strain specific differences can be observed including whether the E. coli mini-F sequence
is maintained. Following HindIII digestion of TB40/E/Cre and TB40/E/Cre GalK/Kanr, a
fragment is present at 6.8 kbp before transfection but is absent after transfection. The
missing band corresponds to the altered E. coli mini-F sequence and its absence shows
the system is functional. Similarly, when digested with EcoRI, a 2.0 kbp band in the
TB40/E and TB40/E GalK/Kanr lanes, regardless of state, indicates the unaltered E. coli
mini-F sequence whereas a band at 7.1 kbp in the TB40/E/Cre and TB40/E/Cre
GalK/Kanr lanes before transfection indicates the modified E. coli mini-F sequence. A 5.9
kbp fragment present in all four BACs is absent in the TB40/E/Cre and TB40/E/Cre
GalK/Kanr reconstituted viruses, demonstrating successful excision of the E. coli
propagation sequence.
Based on our methods of verification, the newly derived BAC plasmids were able
to excise the E. coli propagation sequence upon virus reconstitution in mammalian cells.
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B. Growth of TB40/E/Cre and the effects of genome length.
To examine the relationship between genome length and virion maturation, we
compared growth of TB40/E, TB40/E GalK/Kanr, TB40/E/Cre, and TB40/E/Cre GalK/Kanr
as a function of genome length. Wildtype isolates of HCMV have genome lengths ranging
from ~230-240 kbp. Differences in length can generally be attributed to a mixture of gene
duplications and deletions depending on the strain. Even within certain isolates,
population heterogeneity can contribute to the observed variation in genome length (244).
For TB40/E, the viral encoding region of the genome is approximately 229 kbp in addition
to the 7.5 kbp E. coli propagation sequence. The 1-10 kbp difference in viral coding
capacity of TB40/E relative to directly sequenced isolates is partly due to loss of IRS1US1, part of US2, all of US3-US6, and other mutations which may have resulted from the
initial adaptation of TB40/E as a BAC (244). Because the sequence for the original
TB40/E clinical isolate is unavailable, we are unable to determine which mutations were
directly caused by BAC generation. Therefore, for the purpose of our study, we compared
the lengths of TB40/E and TB40/E/Cre derivatives relative to an approximately 232 kbp
long hypothetical pseudo-wildtype TB40/E sequence (pwTB40/E) consisting of the noted
229 kbp TB40/E viral sequence with a reconstituted US2-US6 region in place of the E.
coli mini-F sequence (Fig. 2.3). Using pwTB40/E as the benchmark, the 7.6 kbp TB40/E
E. coli mini-F sequence replaced a 2.7 kbp portion of the US2-US6 region resulting in a
net length increase of 4.9 kbp. Because TB40/E/Cre excises the complete E. coli mini-F
sequence, the resulting genome length during packaging into the capsid is -2.7 kbp
relative to pwTB40/E, or 229 kbp. Insertion of a 2.3 kbp galK/kanr segment, which is
under control of a bacterial promoter, was then used as a biologically inert surrogate for
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introducing exogenous sequence to the genome of both TB40/E and TB40/E/Cre. After
transfection, genome lengths relative to pwTB40/E are as follows: TB40/E/Cre = -2.7 kbp,
TB40/E/Cre GalK/Kanr = -0.4 kbp, TB40/E = +4.9 kbp, and TB40/E GalK/Kanr = +7.2 kbp
(Fig. 2.3).
To characterize virus replication kinetics, we compared the four strains in singlestep (MOI = 1.0) and multi-step (MOI = 0.01) growth curves in primary human foreskin
fibroblasts (HFFs; Fig. 2.4).

No distinct patterns emerged when comparing the

intracellular or extracellular growth of the strains following high MOI infection except a
slight lag in extracellular TB40/E GalK/Kanr production.

During low MOI infection,

intracellular and extracellular titers for TB40/E/Cre and TB40/E/Cre GalK/Kanr increased
at a faster rate than either TB40/E or TB40/E GalK/Kanr. Unexpectedly, the growth rate
of TB40/E GalK/Kanr appeared to surpass growth of TB40/E by a slight margin despite
having the longest overall genome length. Regardless of differences in growth rate, all
four viruses reached approximately the same titer at the culmination of the time course.
We found a similar pattern when comparing the accumulation of DNase I resistant
genomes over the same time course (bottom panels, Fig. 2.4).

TB40/E/Cre and

TB40/E/Cre GalK/Kanr, with the smallest genomes, grew faster and almost
indistinguishably from each other compared to TB40/E or TB40/E GalK/Kanr. Likewise,
TB40/E GalK/Kanr genomes accumulated more quickly than TB40/E genomes over the
same time course both at the intracellular and extracellular stages. Overall, the growth
curves show that TB40/E/Cre and its derivative grow more quickly than strains that
maintain the E. coli propagation sequence. Additionally, the growth of TB40/E/Cre with
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or without insertion of exogenous sequence is identical allowing greater comparability
during experiments where expression of foreign sequence is required.
In addition to the growth curves and genome abundance, we assessed expression
of the three HCMV kinetic classes of viral proteins (immediate early [IE], early [E], and
late [L]); their successive expression is required for production of infectious virions. IE1/2
(IE), pUL44 (E), and pp28 (L) expression levels were evaluated in immunoblots to monitor
changes in growth in HFFs (Fig. 2.5A).

In comparison to levels of the cellular

housekeeping protein, GAPDH, expression of all three classes appeared identical across
TB40/E, TB40/E GalK/Kanr, TB40/E/Cre, and TB40/E/Cre GalK/Kanr, with the exception
of a slight shift in pp28, suggesting growth differences are largely independent of viral
protein expression.
Lastly, we compared the characteristic CPE produced by each strain to look for
potential issues with spread during infection. HCMV produces a hallmark cytoplasmic
virion assembly complex (cVAC) late in infection following viral protein expression and a
significant alteration in internal host cell architecture. The cVAC is proposed to facilitate
virion maturation and consists of a reniform nucleus with endosomal populations centrally
located in a perinuclear, ring-like, Golgi-derived structure. To monitor cVAC formation,
we used IFA to image structures present in HFFs (Fig. 2.5B).

Infected cells were

identified based on the presence of nuclear viral proteins IE1/2 and cellular structures
were observed using GM130 to mark the cis-Golgi or EEA1 to mark endosome
populations. At an early time point (24 hpi; top panels, Fig. 2.5B), a time prior to cVAC
formation, there were no differences between TB40/E, TB40/E GalK/Kanr, TB40/E/Cre,
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or TB40/E/Cre GalK/Kanr. Similarly, at 96 hpi (bottom panels, Fig. 2.5B), when the cVAC
should be fully formed, no appreciable differences in cellular morphology were detected.
Our observations suggest that differences in growth rate as a function of genome
length are independent of both viral protein expression and cVAC development.
C. Implementation of TB40/E/Cre as a gene transduction vector.
To test the ability of TB40/E/Cre to express a gene of interest, we used the cellular
trafficking protein, Rab3A. Rab3A is a GTPase involved in shuttling cargo from Golgi
compartments to the plasma membrane and is associated with envelopes of HCMV
virions in the cVAC (20, 211, 212).
To express Rab3A from TB40/E/Cre, we first created a TB40/E/Cre derivative that
fuses proteins of interest to ECFP and FKBP tags (Fig. 2.6). The fluorescent protein,
ECFP, allows protein localization to be monitored. FKBP is a destabilization domain that
post-translationally controls protein abundance (264) (Fig. 2.7). In the presence of the
soluble stabilizing ligand, Shield-1, the protein is stabilized and accumulates. In the
absence of Shield-1, the protein is co-translationally degraded by the proteasome. FKBP
allows us to stabilize accumulation of genes of interest on smaller timescales than
typically available through other techniques such as plasmid transfection.
Using recombineering as before, BACs were initially modified in E. coli SW105
cells (Fig. 2.6). After ECFP-Rab11A was tagged with FKBP using the SW105 arabinoseinducible flippase which excises intervening sequence between FRT cleavage sites, the
tagged construct was moved to E. coli SW102 cells containing TB40/E/Cre MIEEnh from
Fig. 2.1. Incorporation of the fragment reconstituted the MIE enhancer/promoter region
(MIEEnh/P) and generated TB40/E/Cre FKBP-ECFP-Rab11A (BAC 7, Fig. 2.6). Rab11A
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was replaced with galK/kanr creating the intermediate TB40/E/Cre FKBP-ECFPGalK/Kanr which directly tags genes of interest for transduction (BAC 8, Fig. 2.6). Lastly,
the selection cassette was replaced by Rab3A and TB40/E/Cre FKBP-ECFP-Rab3A was
completed (BAC 9, Fig. 2.6). As before, each step of the process was verified prior to
transfection and reconstitution of infectious virus (data not shown).
To demonstrate the transduction and stability regulation system, stabilization of
FKBP-ECFP-Rab3A was determined by immunoblot of infected HFFs (MOI = 0.1) using
a time course of Shield-1 additions leading up harvesting of cell lysates at 96 hpi (Fig.
2.8A). Cellular GAPDH and the viral DNA processivity factor, pUL44, was used to monitor
the progression of infection. When stained with an anti-Rab3A monoclonal antibody,
FKBP-ECFP-Rab3A expression is apparent at the predicted size of 70 kDa even in the
absence of Shield-1. The higher molecular weight bands detected by the Rab3A antibody
likely represent post-translationally modified forms of FKBP-ECFP-Rab3A which are
required for normal Rab3A function. Native Rab3A is a cellular protein of approximately
25 kDa in size. Because Rab3A is expressed at relatively low levels in HFFs (data not
shown), it was not detected under the conditions tested due to the significant amount of
FKBP-ECFP-Rab3A present. As measured through densitometry, accumulation of the
Rab3A construct increases as a function of Shield-1 exposure time with an approximately
4-fold increase in abundance occurring in as little as 2 h (Fig. 2.8B). To demonstrate the
reversibility of the system, cells were also exposed to Shield-1 for 12 h, washed, and then
incubated in clean media for another 12 h prior to fixation (12 + wash, Fig. 2.8A and B).
The withdrawal of Shield-1 was sufficient to stop the continued accumulation of FKBPtagged Rab3A leading to identical levels as the 12 h time point. Because Rab proteins
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associate with membranes after being post-translationally modified, the prolonged
persistence of Rab3A following Shield-1 removal may be due to interactions that preclude
it from being routed to the proteasome.
To assess intracellular localization of Rab3A as expressed from this construct,
internal morphologies of HFFs were compared after infection (MOI = 0.1) with
reconstituted TB40/E/Cre or TB40/E/Cre FKBP-ECFP-Rab3A (Fig. 2.8B). Infected cells
were identified using an antibody against the nuclear-resident viral protein pUL44.
Progression through infection correlates with an increase nuclear pUL44 staining,
enabling estimation of the stage of infection in individual cells. GM130 was used to mark
the Golgi-ring and the accumulation and localization of FKBP-ECFP-Rab3A was detected
using its the ECFP tag. Shield-1 was added according to an identical time course as
used for the immunoblots, and cells were fixed for staining at 96 hpi.

As in the

immunoblots, no FKBP-ECFP-Rab3A was detected during TB40/E/Cre infection alone
but a small amount was evident in the absence of Shield-1 during infection with
TB40/E/Cre FKBP-ECFP-Rab3A.

Likewise, the abundance of the stabilized Rab3A

construct increases as a function of time and is markedly different within only 2 h of
Shield-1 treatment. Consistent with previous results, when FKBP-ECFP-Rab3A was
stabilized, it localized to the cVAC and the plasma membrane.

During prolonged

exposure to Shield-1, it appears that excessive accumulation of the Rab construct leads
to collapse of normally occurring Golgi-ring. This alteration may be caused by secondary
or off-target effects of Rab3A expression as Rab3A controlled pathways are required for
normal cell homeostasis.
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V. Discussion
Several BAC systems have been generated to study HCMV in laboratory settings.
The ability to replicate and modify the genome in bacterial culture is a powerful tool for
understanding the viral replication cycle but is typically achieved at the cost of viral coding
capacity due to genome packaging restrictions. This forces researchers to classify viral
sequences as essential versus nonessential despite a lack of functional knowledge and
contextual understanding all which contributes to a loss of biological significance. With
this in mind, a handful of currently available BACs have been designed using a Cre/LoxP
cleavage system to excise the E. coli propagation sequence upon transfection into
mammalian cells.

The Cre/LoxP system decreases the potential for mutations by

alleviating genome length restrictions relative to BACs that maintain the E. coli mini-F
sequence.
Here we describe the adaption of the endothelial-tropic HCMV strain TB40/E to
contain a self-excisable E. coli mini-F sequence resulting in the novel strain TB40/E/Cre.
By adapting a previously characterized strain, we maintain the ability to compare results
from TB40/E/Cre infections to earlier observations. In TB40/E, the E. coli propagation
sequence replaces the US2-US6 viral gene locus, which contains genes with primarily
immunomodulatory roles. In TB40/E/Cre, the US2-US6 deletion is maintained but the E.
coli propagation sequence is lost upon introduction to mammalian cells thus creating a
small surplus of coding capacity that can be used for transduction of exogenous
sequences.
The growth of TB40/E/Cre was compared to the parent strain, TB40/E, and the
insertion strains TB40/E GalK/Kanr and TB40/E/Cre GalK/Kanr. The inclusion of the
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bacterially driven galK/kanr selection cassette was used to test the fitness of TB40/E/Cre
as a mammalian transduction vector without interference from a biologically active
molecule. We show that TB40/E/Cre and its derivative, TB40/E/Cre GalK/Kanr, grew
faster than TB40/E and TB40/E GalK/Kanr at a low MOI (Fig. 2.4). Additionally, the growth
patterns

of

TB40/E/Cre

and

TB40/E/Cre

GalK/Kanr

were

almost

completely

indistinguishable from each other whereas TB40/E and TB40/E GalK/Kanr grew at
different rates relative to each other. This suggests there may be a confounding variable
when expressing exogenous sequence from TB40/E, consequentially reducing its utility
as a transduction vector.

Unexpectedly, TB40/E GalK/Kanr, which contains an

approximately 8 kbp longer genome compared to WT HCMV isolates and the longest
genome of the strains studied here, grew faster than TB40/E alone. There were no
significant differences in viral protein expression or generation of the cVAC in infected
cells (Fig. 2.5A and B).

HCMV strains without a Cre/LoxP system are capable of

preferentially and spontaneously losing all or part of the E. coli propagation sequence
during replication. It may be that TB40/E GalK/Kanr mutants are closer to the threshold
of capsid packaging capabilities so the virus is more predisposed to excising nonessential
gene regions following successive rounds of replication. Future studies looking at the
genetic content of the various strains over the course of infection may help identify the
discrepancies in growth rates.
After demonstrating the ability of TB40/E/Cre to tolerate exogenous sequence, we
incorporated a tagged protein transduction system to regulate the abundance of genes of
interest over short time intervals (Fig. 2.6-8). Compared to generating stable proteinexpressing cell lines or co-transfection/infection experiments, incorporating constructs

54
into TB40/E/Cre simplifies the process of studying genes of interest during infection.
TB40/E/Cre is easily manipulated in bacterial systems and its use as a vector ensures
each infected cell carries a copy of the protein of interest. In this instance, we fused the
host vesicular trafficking protein Rab3A to ECFP and the destabilization domain, FKBP.
By attaching the tags to the N-terminal domain, FKBP is translated first and immediately
targets the construct to the proteasome for co-translational degradation unless the soluble
ligand, Shield-1 is added to the system and stabilizes FKBP. We use the system to show
Rab3A accumulation in infected cells as a function of Shield-1 exposure and demonstrate
proper localization of the construct to the cVAC where endogenous Rab3A has been
identified as having a role in secondary envelopment and virion egress. The presence of
FKBP-ECFP-Rab3A in the absence of Shield-1 may be due to the membrane
sequestration of Rab3A following post-translational geranylgeranylation. Despite the
incomplete degradation, protein accumulation is able to be modified significantly by
addition of Shield-1 with appreciable differences being seen by IFA and Western blot in
as few as 2 h post-Shield-1 exposure.

This is a marked improvement over other

expression systems which typically require 24-48 h before proteins accumulate which is
particularly important given the fast nature of many cellular events.
The application of TB40/E/Cre will facilitate the study of viral replication. The
combination of the self-excisable BAC and titratable nature of the FKBP/Shield-1 system
in TB40/E/Cre gives researchers increasing control of protein accumulation over
decreasing time scales. By using TB40/E/Cre to express inhibitors of cellular processes
over short periods, it will be easier to avoid off-target effects relative to more traditional
techniques such as plasmid transfection. Through proper application, TB40/E/Cre may
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be the key to identifying critical control points in viral replication which we can then use
for development of novel antivirals.
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Table 2.1. Primers used to generate recombinant viruses.
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Table 2.2. Antibodies used for immunoblots and IFA.
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Fig. 2.1. Generation of the self-excisable endotheliotropic HCMV BAC, TB40/E/Cre.
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Fig. 2.1. Generation of the self-excisable endotheliotropic HCMV BAC, TB40/E/Cre. Homologous
recombination in E. coli SW102 cells was used to modify the original TB40/E E. coli mini-F propagation
sequence which replaces the US2-US6 region in the HCMV genome. Alternating rounds of positive and
negative selection with a galK/Kanr cassette were used to insert PCR amplicons containing desired features.
Cre recombinase with a synthetic intron (inCre) was inserted adjacent to the E. coli propagation sequence and
flanked by LoxP cleavage sites. Following transfection, the cre intron is removed and the LoxP sites are
cleaved resulting in loss of the E. coli propagation sequence. Coding sequences are drawn to scale excluding
the E. coli propagation sequence which is represented as one third the normal length. Letter designations
correspond to the primers used in Table 2.1. Abbreviations: unique long region (UL), unique short region (US),
truncated US2 (trUS2), linker region (LR), CMV major IE promoter enhancer region (MIEEnh), SV40 promoter
(SV40P).

Fig. 2.2. Restriction digestion of HCMV DNA before and after transfection shows successful excision
of the E. coli mini-F propagation sequence from TB40/E/Cre derivatives following virus reconstitution.
Equal amounts of DNA purified from E. coli and DNase I treated virions were digested using HindIII or EcoRI
restriction endonucleases. Digests were run overnight on a large format gel and band sizes relative to a
standard DNA ladder (S) were visualized with ethidium bromide. Abbreviations: TB40/E (TB), TB40/E/Cre
(TBC).
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Fig. 2.3. BAC structures and genome lengths following reconstitution relative to a pseudo-wild type
TB40/E (pwTB40/E) strain. pwTB40/E is comprised of the TB40/E sequence with an intact US2-US6 gene
region in place of the E. coli mini-F propagation sequence. Coding sequences are drawn to scale and number
designations correspond to the cloning diagram found in Fig. 1. Abbreviations: truncated US2 (trUS2), linker
region (LR).
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Fig. 2.4. Divergent HCMV genome length-associated growth rates. BAC single-step (MOI 1.0) or multistep (MOI 0.01) HFF growth rates were determined by plaque assay and genome accumulation. Cellular
supernatants were collected for extracellular fractions and remaining cells were washed prior to sonication and
harvesting of intracellular fractions. DNase I protected genomes were detected by qPCR and abundances
were calculated relative to 3 dpi TB40/E samples using the 2-ΔC’T method (3). Error bars represent standard
error of the mean (SEM). Abbreviations: TB40/E (TB), TB40/E/Cre (TBC).
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Fig. 2.5. HCMV genome length-associated growth rates are independent of viral protein expression
and assembly complex formation. (A) Protein expression of BAC infected HFFs (MOI 1.0) using markers
for immediate early (IE1/2), early (pUL44), and late (pp28) viral proteins. (B) Golgi-ring formation and
endosome redistribution indicates HCMV assembly complex formation at late time points of infection in HFFs
(MOI 0.1). IE1/2 nuclei are positive for infection. Abbreviations: TB40/E (TB), TB40/E/Cre (TBC).
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Fig. 2.6. Self-excision of the TB40/E/Cre E. coli mini-F propagation sequence creates a genome length
reduction that can accommodate exogenous sequence.
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Fig. 2.6. Self-excision of the TB40/E/Cre E. coli mini-F propagation sequence creates a genome length
reduction that can accommodate exogenous sequence. Homologous recombination of HCMV BACs in E.
coli strains SW105 and SW102 was used to insert PCR amplicons containing desired sequences through
consecutive rounds of positive and negative selection. The Rab11A cellular GTPase protein was tagged with
ECFP and the destabilization domain, FKBP, using an arabinose-inducible flippase to cleave FRT sites. FKBPECFP-Rab11A was then incorporated into TB40/E/Cre and Rab11A was replaced with the cellular trafficking
protein Rab3A. Coding sequences are drawn to scale excluding the E. coli propagation sequence which is
represented as one third the normal length. Letter designations correspond to the primers used in Table 2.1.
Abbreviations: unique long region (UL), unique short region (US), CMV major IE promoter (MIEP), enhanced
cyan fluorescent protein (ECFP), SV40 polyadenylation site (SV40pA), FKBP destabilization domain (FKBP),
truncated US2 (trUS2), SV40 promoter (SV40P), Cre recombinase with a synthetic intron (inCre), linker region
(LR), CMV major IE promoter enhancer region (MIEEnh), reconstituted CMV major IE enhancer and promoter
region (MIEEnh/P).

Fig. 2.7. Regulation of function by FKBP/Shield-1 stabilization. FKBP tagged constructs are cotranslationally degraded by the proteasome unless reversibly stabilized by the soluble Shield-1 ligand.
Abbreviations: CMV major IE enhancer and promoter region (MIEEnh/P), SV40 polyadenylation site (SV40pA).
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Fig. 2.8. Enhanced accumulation of FKBP tagged Rab3A can be detected within 2 h of exposure to
Shield-1. (A) Immunoblot analysis showing accumulation of FKBP-ECFP-Rab3A (70 kDa) in infected HFFs
(pUL44; MOI 0.1) following addition of Shield-1. Shield-1 was added at indicated times prior to harvest of cell
lysates at 96 hpi. (B) Densitometry analysis of immunoblot in (A). Error bars represent standard error of the
mean (SEM). (C) IFA time course of Shield-1 addition showing accumulation and localization of FKBP-ECFPRab3A relative to the Golgi-ring (GM130) in infected HFFs (pUL44; MOI 0.1). Shield-1 was added at indicated
times prior to fixation and staining at 96 hpi. Abbreviations: TB40/E/Cre (TBC), mock infected control (M).
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CHAPTER 3: REGULATION OF THE HOST CYTOPLASMIC COMPARTMENT BY HCMV
INFECTION
I. Abstract
Human cytomegalovirus (HCMV) is a persistent pathogen for individuals without
functionally competent immune systems.

Failure to understand viral assembly has

resulted in limited antiviral treatments and the unique biology of HCMV infection has
eluded protection by vaccination.
During infection, HCMV causes the dramatic reorganization of host intracellular
structures thereby causing formation of the cytoplasmic virion assembly complex (cVAC).
The cVAC promotes virion maturation by constituting a viral assembly line.
To understand the role of cellular components during infection, we characterized
the role of cellular structures within the endocytic recycling compartment (ERC) as they
relate to cVAC formation and virion maturation.

We used previously generated

transcriptional and proteomic data sets to map regulation of cellular trafficking
components throughout the ERC. As a result, we have generated a model for cVAC
development and virion maturation which suggests formation of a perinuclear secretory
trap utilized for virion assembly and eventual egress using secretory vesicle-like
pathways. Using our model, we are able to provide context for previous observations
during HCMV replication and provide future opportunities for the development of HCMV
specific treatments.
II. Introduction
Human cytomegalovirus (HCMV) is a common viral pathogen capable of causing
severe complications in immunologically compromised or naïve individuals. A lack of
antiviral target diversity has led to the emergence of antiviral-resistant strains, thereby

67
removing the last line of defense for patients unable to control the infection. By increasing
our understanding of cytoplasmic events during HCMV replication, we can identify and
exploit potential targets for the generation of novel therapeutics.
As part of normal HCMV replication, HCMV induces the hallmark reorganization of
internal cellular structures at time points late in infection. The restructuring of cellular
components leads to the formation of the cytoplasmic virion assembly complex (cVAC)
which is proposed to act as a viral assembly line leading to the directed sequential
addition of the structural components required to generate nascent virions. The cVAC is
a perinuclear structure consisting of a Golgi-derived ring structure with endosome
populations at the center. Formation of the cVAC is dependent on cooperation between
viral and cellular factors through a process that is not yet understood.
As part of the structural alterations, characteristic membrane populations
experience a shift in marker protein identities (19, 23).

This shift complicates the

classification of host cell-derived membranes used during virion envelopment and egress.
Several observations suggest virion envelopes are Golgi-derived and follow a path similar
to secretory vesicle (SV) formation and exocytosis (20, 23, 29, 32, 33, 35). Others have
looked at the effect of viral regulatory mechanisms on cellular transcripts and protein
abundance (2, 23, 266). While individual proteins or processes have been implicated in
virion development, an overall map of HCMV-induced trafficking has not yet been
presented.
In this study, we utilize previously available data sets to examine the trafficking
regulatory processes in the context of HCMV infection. For generation of our model, we
map alterations to cellular pathways through the endocytic recycling compartment (ERC)
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(Fig. 3.1). The ERC is a functional characterization of normal cellular transport and is
required for maintaining homeostasis under normal conditions (reviewed in (267)).
Trafficking through the ERC is dependent, in part, on membrane-bound GTPases,
including the Rab family of proteins, and various effector molecules attaching to the
cytoskeletal network. Importantly, ERC pathways are highly conserved in all cell types.
In this study, we combine the analysis of transcriptional and proteomic data sets
to analyze cellular trafficking throughout the ERC as a function of HCMV infection.
Through the use of data transformation and a novel metric, we are able to examine global
cellular trafficking regulatory patterns induced by viral factors. Our model provides a
framework for understanding derivation of host membranes for use in cVAC development
and details potential routes of virion egress. In our model, we provide further evidence
suggesting HCMV utilizes a SV-dependent pathway for virion envelopment and egress.
Using our model of virion maturation, we provide context for studies examining
cytoplasmic events during virion growth. It also provides the opportunity for targeting key
regulatory elements which can be exploited for inhibiting HCMV infection in host tissues.
III. Methods
A. Cells and virus.
The viruses used in this study were HCMV Towne, provided by Thomas Shenk
(Princeton University, Princeton, NJ), AD169 (ATCC), and AD169-dervied bacterial
artificial chromosome (BAC) strain, pAD/Cre, provided by Dong Yu (Washington
University, St. Louis, MO). Viruses were grown in low-passage-number pooled human
foreskin fibroblasts (HFFs) in complete Dulbecco’s modified Eagle medium (DMEM;
Hyclone, Logan, UT; catalog no. SH30243.01) supplemented with 1% nonessential amino

69
acids (Hyclone, Logan, UT; catalog no. SH30238.01), 1% GlutaMax (Gibco,
Gaithersburg, MD; catalog no. 35050-061), and 10% fetal bovine serum (FBS; Atlanta
Biologicals, Atlanta, GA; catalog no. S11150). Virus was titrated by standard plaque
assay in HFFs.
B. Transcriptional and proteomic data sets of HCMV infected cells.
Generation of the transcriptional microarray dataset in our lab has been previously
described (1). Briefly, low passage HFFs were mock treated or infected at an MOI of 6.0
using Towne or AD169 and incubated for 12 or 96 h. Upon harvest, RNA was Trizol
extracted (Life Technologies, Grand Island, NY; catalog no. 15596-018), and RNA quality
was assessed. RNA samples were then loaded onto Illumina HT-12 v4 human bead
array chips for detection. Setup of the assay and reading of the chips was done at the
Wayne State University Advanced Genomics Technology Center (Wayne State
University, Detroit, MI). Results were reported as individual signal intensities.
Generation of the proteomic dataset has also been previously described (2).
Briefly, HFFs were infected at an MOI of 10 using the HCMV bacterial artificial
chromosome (BAC) strain Merlin. Following appropriate incubation periods, plasma
membrane and whole cell lysate samples were isolated, enzymatically digested, and
labelled using tandem mass tag (TMT) 8-plex and 10-plex reagents. Labeled samples
were then subjected to liquid chromatography and tandem mass spectrometry. For our
analysis, available data sets are reported as relative abundances.
C. Bioinformatics analysis.
Initial analysis of microarray data was done using BRB-ArrayTools (v. 4.2.0 beta
2) from Dr. Richard Simon and the BRB-ArrayTools Development Team. Microarray data
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for 12 and 96 hours post infection (hpi) samples were compared to mock using the
significance analysis of microarray (SAM) function with a false discovery rate of 0.01.
A heatmap of SAM significant genes of interest was generated in R using the limma
and gplots packages. Clustering was done using Pearson’s correlation coefficient and
an average-linker method. Results were normalized on the basis of each individual row
and reported as row Z-scores centered around the mean log2 intensities.
Graphical analysis of dataset relationships was also done using R and r value was
calculated using Pearson’s correlation coefficient.
D. Transmission electron microscopy.
Infection and imaging of cells infected with the AD169 BAC strain, pAD/Cre, in our
lab was previously described (21). In brief, HHFs were infected at an MOI of 0.3 and
infections progressed for 120 hpi. Cells were fixed and sent to Dr. Hong Yi at the Robert
P. Apkarian Integrated Electron Microscopy Core Facility of Emory University (Atlanta,
GA) for staining and imaging.
IV. Results
A. Vesicular transport proteins are differentially regulated over the course of
infection
To generate a model of HCMV trafficking within cells, we used a previously
generated microarray dataset from our lab to examine transcriptional regulation of vesicle
transport during infection with HCMV at early and late time points in viral replication (1).
Following infection with HCMV variants Towne and AD169, the cellular transcriptional
profile of ~25,000 genes, represented by 47,213 probes, was measured relative to a mock
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infected control. By comparing triplicate samples from 12 and 96 hpi, the progression of
virally induced transcription regulation was able to be monitored.
Following significance analysis of microarray (SAM) profiling of the transcriptional
dataset, probes that passed the filter were examined for roles in cellular vesicle mediated
transport. Probes were identified based on known gene ontology classifications and
thorough reviews of related literature. In total, 328 probes, representing 328 unique
genes, with known functions in vesicular transport were identified.
For a comprehensive overview of regulatory patterns, a heatmap was generated
representing the transcriptional profiling of the 328 probes (Fig. 3.2). Construction of the
heatmap used Pearson’s correlation coefficient to group transcripts based on individually
normalized standard deviations around the mean log2 expression values. Clustering was
then performed using an average-linkage method.

When examined, the heatmap

displays four distinct regulatory patterns including upregulation and downregulation of
transcripts at both 12 and 96 hpi. To establish a model of trafficking pathways, the
transcriptional data was then compared to measured cellular protein abundances.
B. Transcriptional regulation of HCMV infection correlates with cellular protein
abundance
Because transcriptional patterns don’t completely correlate with protein translation
or protein stability, we compared the whole microarray dataset to a previously
characterized proteomic dataset (2). The proteomic data was generated from a series of
experiments analyzing whole cell lysate and plasma membrane specific fractions of
cellular proteins. Importantly, the proteomic data contained slightly over 8,000 detected
proteins so comparison between the two sets were based on only those detected in both
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sets. Because the proteomic data was represented as the relative abundance over a
series of time points, a summary metric was devised that could be applied to both the
transcriptional and proteomic profiles. This was possible because we were interested in
the general regulation of pathways over time and not in absolute values.
To transform the data, transcript signal intensities and protein abundance data
were independently averaged across all replicates at 12 and 96 hpi. Then, the averages
were respectively normalized to control values from mock infected cells resulting in the
transcript/protein level fold change (FC) relative to mock.

FC values were log2

transformed and FC12hpi was subtracted from FC96hpi to give the change in log2 FC
(Δlog2FC) as seen below.
∆𝑙𝑜𝑔2 𝐹𝐶 = 𝑙𝑜𝑔2 (

96ℎ𝑝𝑖
12ℎ𝑝𝑖
) − 𝑙𝑜𝑔2 (
)
𝑚𝑜𝑐𝑘
𝑚𝑜𝑐𝑘

By summarizing both data sets using the Δlog2FC metric, which is reported in
arbitrary units, we focus on the patterns of regulation instead of the absolute values. Next,
the Δlog2FC values for the Merlin infected proteomic data were graphed against the
transcriptional data from AD169 infected cells using a standard coordinate axis (Fig. 3.3).
Comparison of regulatory patterns resulted in a value of r = 0.46 showing the
samples are positively correlated but there are still substantial differences.
C. HCMV infected cells favor a secretory vesicle mediated exocytic pathway.
Because the two data sets were overall positively correlated, we proceeded to use
the microarray data for establishing a model of HCMV infection because the data were
more robust. Using the established roles of the 328 identified probes in regard to positive
regulators versus negative regulators of specific pathways, the Δlog2FC regulatory
patterns were mapped onto pathways throughout the ERC.
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The resulting downregulation of all major exocytic pathways and upregulation of
all major endocytic pathways with the exception of those required for SV exocytosis
suggest a novel pathway for virion egress (Fig. 3.4). By transcriptional analysis, it
appears that HCMV drives SV vesicle exocytosis leading to compound exocytic events.
Indeed, through imaging by electron microscopy, vesicles containing multiple mature
virions and other particles are evident (Fig. 3.5).
V. Discussion
During HCMV infection, virally-induced processes dramatically alter the internal
cellular morphology leading to formation of the cVAC (17, 18). As part of the remodeling,
several pathways required for normal homeostasis are rerouted or dissociate resulting in
an apparent perinuclear secretory trap (19, 42, 44).
By using previously available data, we were able to construct a model of HCMVinduced changes to host secretory systems. While informative, there are a few potential
factors that may confound our analysis: i) the viral strains used were different between
data sets, ii) the experiments were not setup exactly the same (i.e. MOI of 6.0 versus
10.0), iii) the selection of probes related to transport are subject to individual bias, and iv)
mapping of changes to pathway flux is somewhat subjective. While the setup has its
flaws, there were still enough correlations to justify use of these data sets for preliminary
experiments.
Consistent with previous observations of secretory regulation by HCMV, our
modelling predicts a change in the net flux of ERC pathways (19, 20, 42, 44). Under this
model, we predict that HCMV promotes the perinuclear accumulation of various
components within cells. The concentration of materials in an area coincident with cVAC
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development then facilitates cytoplasmic events required for virion maturation (Fig. 3.6).
The apparent upregulation of cellular transcripts required for SV vesicle release suggests
SV exocytosis may serve as a final pathway for virion egress.
This is supported by previous observations relating virion envelope lipid
composition to synaptic vesicles, which follow a similar trajectory, and findings that of SV
trafficking proteins associated with HCMV envelopes (20, 29, 32, 33). Additionally, SV
exocytosis is mediated through a Ca2+ dependent mechanism and during infection with
HCMV, Ca2+ levels are maintained at substantially elevated levels throughout infection
(50). Because SV pathways are highly conserved across diverse cell types, they provide
an attractive avenue for HCMV envelopment and egress.
Given the opportunity for further investigation, the various pitfalls could be
controlled for and the relationships could be examined in more detail. Using the Δlog2FC
metric under improved conditions may also lead to insight related to regulation of
transcriptional activity and protein expression as a result of infection. While approximately
half of the investigated transcripts/proteins appeared to follow the same general
regulatory pattern, there were some that exhibited increased transcription but decreased
protein abundance and vice versa. These techniques can also be applied in the context
of infection with other viruses to study viral replication. Understanding the relationship
between transcripts and proteins may give context to the effects we see during HCMV
infection and cVAC biogenesis.
Through use of our model, we are able to target the various trafficking events that
appear to be important for virion maturation. By interfering with key steps, we can identify
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critical control points and either validate or improve our current model with the goal of
eventually exploiting control points for the development of new therapies.
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Fig. 3.1. Features of the endocytic recycling compartment (ERC). The endocytic recycling compartment
is a functional classification of cellular trafficking events required to maintain homeostasis. Under normal
circumstances, inbound materials enter through early endosome (EE) populations before being routed
elsewhere such as common recycling endosomes (CRE) or degradative pathways (LE, MVB, LYS). Secretory
vesicles (SV) are also generated in this compartment using CRE and Golgi (GA)- derived membranes. During
SV exocytosis, vesicles are transported to the plasma membrane and released either independently or through
compound exocytosis. Abbreviations: endoplasmic reticulum (ER), Golgi apparatus (GA), common recycling
endosomes (CRE), early endosomes (EE), apical recycling endosomes (ARE), late endosomes (LE),
multivesicular bodies (MVB), lysosomes (LYS), secretory vesicles (SV).
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Fig. 3.2. Heatmap demonstrating regulation of cellular trafficking during HCMV infection. HCMV
infected HFFs (Towne and AD169; MOI 6.0) were harvested at indicated time points and RNA was extracted
for microarray analysis as reported previously (1). Following significance analysis of microarray (SAM) relative
to mock cells, 328 significant probes were identified as having roles in vesicle-mediated transport. A heatmap
was generated based on standard deviation around the mean log2 intensity for each individual row. Distance
matrices were calculated using Pearson’s correlation coefficient and clustering was completed using an
average linkage method. Reported Z-scores represent standard deviations from the mean.
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Fig. 3.3. Comparison of proteomic and transcriptional regulation during HCMV infection. Using data
sets generated previously (1, 2), proteomic data from HCMV Merlin infected HFFs (MOI 10.0) was compared
to transcriptional data for HCMV AD169 infected HFFs (MOI 6.0). By transforming the data using the Δlog2FC
of protein abundance or transcript intensity relative to mock infected cells, the variation in regulatory patterns
of proteins and transcripts during infection was compared. Data represents patterns connecting 12 and 96 hpi
relative to mock. Abbreviations: plasma membrane proteome samples (PM), whole cell lysate proteome
sample (WCL)
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Fig. 3.4. HCMV induced upregulation of secretory vesicle (SV) exocytosis during infection. Following
significance analysis of microarray (SAM) filtering, probes were selected for their role in vesicle mediated
transportation. As opposed to increased endocytic flux of other pathways in the endocytic recycling
compartment, SV vesicle exocytosis-associated transcripts increased. The schematic represents trafficking
events required for SV exocytosis with green labeled proteins being upregulated or red labeled proteins being
downregulated as a function of HCMV infection. As the figure moves to the right, SVs encounter the plasma
membrane and undergo single or compound exocytic events. The graph shows the relative transcript levels
of identified proteins over the course of infection with HCMV AD169 or Towne at early (12 hpi) and late (96
hpi) time points.
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Fig. 3.5. Ultrastructural analysis of HCMV infected cells suggests virion egress by compound
exocytosis. Representative images of HFFs infected by the AD169-derived bacterial artificial chromosome
(BAC) pAD/Cre (MOI 0.3) show the accumulation of multiple mature viral particles packaged within individual
vesicles (red).
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Fig. 3.6. HCMV induced alterations to trafficking within the endocytic recycling compartment (ERC)
based on transcriptional data. Following significance analysis of microarray (SAM), 328 significant
transcripts were identified as being involved with cellular vesicle-mediated transport. The effects of
transcriptional regulation during infection were mapped onto the various pathways within the ERC. The
resultant diagram showcases changes in the net flux of various ERC pathways and resultant increase in
secretory vesicle exocytosis. Thickness of arrows indicates change in flux relative to uninfected cells with
thicker arrows being the favored direction of transport. Abbreviations: endoplasmic reticulum (ER), Golgi
apparatus (GA), common recycling endosomes (CRE), early endosomes (EE), apical recycling endosomes
(ARE), late endosomes (LE), multivesicular bodies (MVB), lysosomes (LYS), endosomal sorting complex
required for transport (ESCRT, E).
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CHAPTER 4: GENERAL CONCLUSIONS
Herpesvirus replication cycle relies heavily on remodeling host environments to
achieve envelopment and egress of nascent particles.

While similar high order

requirements exist between the different subfamilies of Herpesviridae, details of virion
replication differ based on the repertoire of cells infected by each virus. Areas of observed
differences include development of an assembly compartment, function of virion structural
proteins, composition of virion envelopes, and mechanisms required for membrane
scission and virion egress.
In general, herpesviruses hijack host trafficking pathways and direct virion
components to a defined assembly region in infected cells, the HCMV cVAC being the
most prominent, before exocytosis of fully matured particles. Redirection of trafficking is
a result of transcriptional regulation, a complex network of viral protein interactions, and
modifications to the metabolic profile of host cells. Key proteins have been identified as
having a role in virion maturation but interpretation is difficult due to functional
redundancies and downstream cascades of interactions.
As part of this research, we generated a series of novel tools and ideas that will
continue to advance the study of HCMV replication. Through the BAC, TB40/E/Cre,
genes of interest can be expressed in the context of infection. Through manipulation of
cellular and viral processes we will be able to identify pathways integral to HCMV
maturation. Through our model of HCMV induced changes to cellular trafficking, we have
identified a series of potential targets for further characterization and potential
development of novel therapeutics.
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By combining all of these advances, functional mutants of cellular trafficking
proteins, such as Rab GTPases, can be expressed during infection to inhibit pathways
identified as critical control points for virion egress as evidenced by changes in the net
output of nascent virions. Likewise, mutated forms of viral proteins purported to be
involved in virion maturation and egress could be expressed to look for similar endpoints.
Based on prior evidence of cell-specific activities, it will be important to assess trafficking
events in all cell types permissive to HCMV infection, particularly epithelial, endothelial,
and monocytic lines. Only by using a comprehensive approach will new antiviral targets
be identified.
There are still many unanswered questions left but with the advent of new and
improved technology, we will be able to probe deeper into depths of virion replication,
expanding our knowledge one particle at a time.
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NAVIGATING HUMAN CYTOMEGALOVIRUS (HCMV) ENVELOPMENT AND
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Human cytomegalovirus (HCMV) is a ubiquitous viral pathogen. In individuals with
fully functioning and mature immune systems, HCMV is associated with mild symptoms
prior to establishing latency. In individuals with naïve or compromised immune systems,
HCMV is capable of causing severe organ damage. HCMV is the leading infectious cause
of congenital birth defects and a major non-genetic cause of hearing loss. Unfortunately,
antiviral treatment options lack diversity due to limited knowledge of virion replication. If
HCMV replication were better understood, new antiviral treatments could be developed.
In this work, we describe the development and implementation of new tools to
study HCMV replication with a focus on envelopment and egress. We generated a novel
HCMV bacterial artificial chromosome (BAC) expression system for characterizing the
effects of exogenous proteins in the context of HCMV replication. While demonstrating
the new BAC, TB40/E/Cre, we are also able to draw conclusions relating HCMV genome
size to replication efficiency. In addition, we characterize the transcriptional profile of
cellular proteins during HCMV infection.

We found that HCMV causes significant

alteration in host mRNA expression and targets a number of transcripts related to vesicle-
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mediated trafficking. By tracing the effects of HCMV on cellular trafficking, we propose a
model of virion envelopment and egress.
Through this work, we now have the capability to test our predictions and
determine the route of viral maturation and exocytosis in host cells. By constructing a
map of HCMV replication, we provide critical control points for use in developing novel
antiviral therapies.
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